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ABSTRACT 
Adhesion of carbohydrate binding proteins called lectins to cell membrane components 
mediates pathogen interactions with host cells. In working with cell membrane mimicking lipid 
bilayers, we observed that weak affinity receptors could be activated by high affinity receptors 
leading to significantly higher binding of the pentameric lectin cholera toxin subunit B, CTB. 
Weak receptor activation was probably mediated via the Reduction of Dimensionality (RD) 
mechanism. In RD, once a protein has attached to a strong receptor, subsequent binding events 
are confined to a two-dimensional cell membrane surface enabling weak affinity receptors to be 
secondary receptors due to the enhanced effective concentration. Based on our CTB experiments, 
we expected that the inherent RD mechanism could induce heteromultivalent binding in most 
multivalent systems. 
To confirm RD as a fundamental mechanism, we studied a second multivalent binding 
lectin. This lectin, LecA, is a tetrameric lectin that mediates Pseudomonas aeruginosa adhesion 
to host cells and biofilm formation. Our data showed enhanced LecA binding to mixture bilayers 
composed of both Gb3 and moderate or weak affinity receptors. Furthermore, moderate affinity 
receptors enhanced weak affinity receptors. Interestingly, our data showed that multivalent 
binding affinity and binding capacity were not necessarily correlated with their monovalent 
counterparts. A colloidal aggregation assay of LecA interacting with Gb3 and LacCer 
demonstrated that LecA’s binding affinity was Gb3 > Gb3+LacCer > LacCer. The colloidal 
binding affinity agreed with prior data binding affinities confirming that multivalent binding 
affinity and binding capacity cannot be assumed from monovalent data.  Therefore, our data 
suggest the RD mechanism is a fundamental multivalent binding mechanism. To efficiently 
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discover hetero-multivalency in various multivalent systems, we developed a turbidity-based 
emulsion agglutination (TEA) assay amenable to high-throughput screening of lectin binding. 
This assay utilizes the coagulation of emulsions to determine heteromultivalent binding. The 
results of the TEA assay matched our prior LecA data and were corroborated by dynamic light 
scattering.  In summary, we have demonstrated the RD mechanism, verified that the RD 
mechanism can play a role in multiple multivalent systems, and developed an assay to efficiently 
screen large molecular libraries for heteromultivalent binding resulting from the RD mechanism. 
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“Our imagination is stretched to the utmost, not, as in fiction, to imagine things which are 
not really there, but just to comprehend those things which are there.” [sic] 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
In biological systems, chemical species are generally dilute, often no more than 50 μM.2 
However, biological systems are clearly still capable of accomplishing necessary chemical 
reactions on biologically relevant timescales. One way biology addresses the issue of dilute 
chemical species is by localizing the reacting species.
3-6
 This can be done by compartmentalizing 
the species onto the same surface or the same region.
3-6
 One example of this is membrane 
partitioning of intestinal epithelial cells into apical and basolateral membrane sections separated 
by tight junctions.
7
 Another example is the general orientation of cell glycolipids toward the 
extracellular milieu.
7,8
 The result of this compartmentalization is that the chemical species 
interact much sooner than if they were freely diffusing enabling reactions to occur on relevant 
time scales.
5
 
However, not all chemical species that interact start localized to the same cell, much less 
to the same region. Two common examples of this are host-pathogen interactions and cell-cell 
communication.
9-13
 An example of one host-pathogen interaction is influenza (specifically strain 
A/Oklahoma/323/03) binding to sugar groups containing a terminal α2-6-linked sialic acid such 
as are found in the human body.
14
 An example of cell-cell communication is proinflammatory 
secretagogues activating P-selectin for leukocyte recruitment. After activation, P-selectin binds 
to P-selectin glycoprotein ligand-1 on leukocytes to contribute to leukocyte recruitment in 
inflammation.
14
 Therefore, this type of cross-cell interaction requires a way to recognize the 
region where the partner chemical species is located. This typically is achieved using multivalent 
proteins that recognize cell membrane receptors. 
13
 
 2 
 
What is Multivalency? 
Multivalent proteins are proteins that contain multiple binding sites, such as the 
pentavalent (five binding site) Cholera Toxin subunit B (CTB) from Vibrio cholerae and 
tetravalent PA-IL (LecA) from Pseudomonas aeruginosa.
15,16
 Now, these multivalent proteins 
typically bind differently than the classical concept of protein binding.
13
 Unlike the traditional 
lock and key model, these multivalent proteins, often, do not specifically recognize a single 
receptor.
13
 Rather these multivalent proteins bind a wide range of receptors, albeit with varying 
degrees of binding affinity.
13,17,18
 However, one should not conclude that the total binding of 
these multivalent proteins is weak. The cumulative binding of multiple weak binding events is 
strong.
13
 This becomes problematic due to the vast array of potential receptors present on the 
typical cell membrane.
13
 Therefore, to understand multivalent protein binding, it is necessary to 
know the binding affinity of the multivalent protein to many different receptors. This introduces 
part of the complexity of understanding multivalent protein binding.  
There is also the issue of multivalent proteins sharing primary receptors, but binding 
differently to the same type of cell.
19-21
 Two multivalent proteins are considered to have a shared 
primary receptor when both proteins have the same receptor as their highest binding affinity 
receptor.
17
 One such pair is Shiga Toxin from Escherichia coli and LecA. Both have 
globotriaosylceramide (Gb3) as their highest affinity receptor.
20,21
 Another example of this is 
Amaranthus caudatus lectin, Agaricus bisporus lectin, Colchicum autumnale lectin, Maackia 
amurensis lectin I, and Phytolacca Americana lectin all bind to the structure β-galactose-N-
acetyl galactosamine (Galβ-GalNAc).19 In all of these cases, if we only consider monovalent 
binding, one would assume that each of these proteins would exhibit binding to cells in 
proportion to their observed binding affinities. However that is not the case, the in vitro and in 
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vivo binding of these multivalent proteins to various cell lines demonstrates that each multivalent 
protein binds differently to a given cell line.
22
 Therefore, it is important to not only consider the 
binding affinity of the multivalent protein to a given receptor by itself, but also to study the 
receptor-protein interaction in its proper context.
17
 This summarizes the effects of hetero-
multivalency.  
Multivalency in Cell Membranes 
Some of the most typical cell membrane receptors for multivalent proteins are glycolipids 
and glycoproteins.
13
 These are lipids and proteins, respectively, which have sugar groups 
attached to them.
13
 Lectins are proteins that recognize the sugar groups on cell membrane 
receptors, typically via multivalent interactions.
13
 Originally, lectins were primarily used for 
blood typing.
13
 Since the 1960s, lectins have been shown to play a role in multiple areas and are 
widely used in biochemistry and biology.
14
 One application is using lectins as stains for detecting 
and quantifying the presence of glycolipids on cell membranes.
23,24
 Lectins, i.e. galectins, are 
also being used as cancer markers.
14
 Increasingly, research has focused on targeting lectins for 
drug delivery or viewing lectins as virulence factors that can be treated.
25-28
 Thus, it is becoming 
increasingly important to understand how multivalent proteins, especially lectins, bind and 
interact with the cell membrane. 
Despite the importance of understanding lectin binding and the wide spread use of 
lectins, we still have several fundamental questions to answer about how lectins interact with cell 
membranes. As mentioned earlier, the question has been raised of why lectins that have the same 
shared primary receptor bind differently to the same cell line.
17
 Similarly, it has been observed 
that lectins used for staining for a given glycolipid do not always correlate with antibody binding 
for that same glycolipid, but no explanation has been given as to why this is.
29
 Furthermore, the 
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governing mechanism behind lectin binding is uncertain.
18
 This hinders our ability to understand 
more application oriented question such as how lectins can bind to cells when their strongest 
affinity receptor is of low abundance.
30
 An example of this is CTB can bind to cell lines that 
have < 0.003 mol% GM1.
31
 In summary, there is much we do not know about lectin binding. 
Despite a lack of direct answers to how lectins interact with cell membranes, the 
literature has observed that lectins can bind to receptors in mixtures that they do not bind to as 
individual receptors. Klassen et al. have done work demonstrating that CTB can bind to mixtures 
of glycolipids using pico-discs and micelles as part of Catch and Release Electrospray Ionization 
Mass Spectroscopy (CaR-ESI-MS).
32,33
 However, the mechanism of how the lectins bind to 
receptor mixtures is still unclear.
33
 Therefore, while it is insightful to demonstrate that CTB can 
bind to receptors in a mixture that it would not individually; it is hard to understand the 
fundamental interactions at work in this system. Other groups have used binary mixtures of 
glycolipids in combinatorial arrays of 1:1 ratios and studied lectins binding to these mixtures.
34
 
In this set up, it was also shown that lectins bound differently to the mixtures as opposed to the 
individual glycolipids.
34-37
 However, none of the authors provided potential mechanisms or 
studied unequal mixtures limiting direct comparisons to real cell membranes.
32-37
 Therefore, the 
evidence of lectins binding differently to mixtures of receptors than they would to the receptors 
individually has been demonstrated in in vitro as well as the aforementioned in vivo systems. 
However, the limited scope of the measurements and lack of a model hinders the translation of 
these results into meaningful answers to questions of lectin binding. 
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Mechanistic Features of Multivalency 
In systems similar to lectins, researchers have begun looking more at the potential 
mechanisms behind multivalent binding to cell membranes. Looking at bivalent antibody 
staining for glycolipids, Mazor et al. noted that there was improved binding affinity if the 
antibody was localized to the membrane surface.
38
 This phenomenon was explained using a 
model given by Sengers et al. that demonstrated the difference between two-dimensional and 
three-dimensional reaction rates.
39
 Sengers et al. showed that two-dimensional reaction rates can 
be up to 10
4
 times greater than those in three-dimensional.
39
 Therefore, it is possible some of the 
differences between observed binding between lectins and their receptors individually as 
opposed to the receptors being present as a mixture can be explained by the difference between 
two-dimensional and three-dimensional reaction rates. However, these studies focused on 
bivalent antibodies. Therefore, this research highlights differences between free versus localized 
reactions as important mechanistic features of multivalent binding, but it is unclear if this is 
translatable to lectin binding. 
Research into lectin inhibition has also provided some potential mechanistic insights into 
how multivalent lectins interact with multiple receptors. Using glycodendrimers (chemical 
species with multiple antenna displaying the same sugar group, or glycan), Imberty et al. have 
demonstrated that using multiple copies of a high binding affinity glycan linked together results 
in the resulting glycodendrimer having a higher binding affinity to LecA than the sugar group by 
itself.
27,40-42
 This is not unique to LecA, but has been demonstrated by other researchers for 
lectins such as the homotetrameric Concanavalin A from Canavalia ensiformis (Jack bean) and 
the aforementioned CTB.
43,44
 
45,46
 Similarly, it has been observed that glycodendrimersomes 
(particles that are coated with multiple copies of a glycan tethered to the surface) can bind to 
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lectins with higher affinity than the same glycan in solution.
47-50
 As part of the design of these 
glycodendrimers and glycodendrimersomes, it has also been shown that the spacing between the 
glycans directly affects their binding affinity.
27,50
This demonstrates that glycan density alters 
multivalent lectin binding and identifies the second mechanistic feature of multivalent binding. 
Research Aims 
The presented research has built off this prior research by focusing on three things.  First, 
we demonstrated why lectins that have the same shared primary receptor bind differently to the 
same cell line. Second, we provided and validated a mechanism to explain multivalent lectin 
binding in two lectin systems. Third, we built off the fundamental understanding gained to 
develop a facile TEA assay to efficiently screen for lectin binding capacity to lipid surfaces using 
only common laboratory equipment. Underpinning this endeavor was a novel nanocube sensor 
developed by Dr. Hung-Jen Wu.
51
 The nanocube sensor is comprised of a label-free silver 
nanocube sensor coated with a silica shell that acts as a surface to form a fluidic supported lipid 
bilayer.
17,51
 In addition, the nanocube sensor is a freely diffusing colloidal probe, which allows it 
to be compatible with UV/Vis well plate readers for high-throughput quantification.
17
 This 
nanocube sensor directly addresses many of the problems faced by research groups in the 
literature.  
Limitations of Current Tools 
Unlike the nanocube sensor, prior tools fixed the glycan spacing creating an environment 
that is dissimilar to the cell membrane. As previously noted, appropriate spacing of glycans is 
important to achieve improved binding affinity. This has created problems for many of the high 
throughput analysis methods, such as glycoarrays, used to study lectins. These problems result 
from either the glycolipids or the lectin being printed onto a surface thereby fixing the spacing of 
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the glycans or potentially inhibiting normal lectin function or rearrangement.
35,52-54
 The 
nanocube sensor addresses this problem by way of the supported lipid bilayer.
17,51
 This bilayer is 
fluidic allowing constituent glycolipids to achieve the appropriate spacing and still effectively 
model the cell membrane.
17,51
 Prior research has also used fluidic lipid bilayers to study lectins, 
i.e. supported lipid bilayers in the Biacore system or micelles as part of mass spectroscopy 
studies.
55-59
 However, these methods are labor intensive, time consuming, and/or required 
specialized equipment.
55-59
 These limitations have likely prevented the widespread use of the 
prior techniques to study lectins. Furthermore, these concerns are especially relevant to studying 
lectin binding to heterogeneous glycolipid bilayers (bilayers containing mixtures of glycolipids) 
because of the necessity to study not only each receptor individually, but also mixed with other 
receptors in varying receptor densities and lectin concentrations. Therefore, there are a wide 
variety of experimental conditions to be tested. This is not a problem for the colloidal nanocube 
sensor because is compatible with a 384 well plate format.
17,18
 Furthermore, the nanocube system 
also avoids the potential problems resulting from the labelling of either lectins or glycolipids that 
are common with many similar techniques such as fluorescence spectroscopy.
60,61
 This label-free 
quantification is possible because the nanocube sensor relies on changes in the local dielectric 
constant caused by the protein displacing buffer near the sensor rather than a tag to identify 
protein binding. This detection by changes in local dielectric constant is a phenomenon called 
localized surface plasmon resonance (LSPR).
17,18
 Thus, the nanocube sensor is a novel 
technology that facilitated the in depth binding analysis required for the successful completion of 
our research by coupling an easy-to-use, label-free supported lipid bilayer sensor to a high-
throughput format.  
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Overview of Following Chapters 
In the following chapters, we will go into further detail about our specific research. 
Chapter II will focus on developing the basics of homogeneous binding and begin to explore 
heterogeneous binding of CTB to various glycolipids. Chapter III will expand upon CTB binding 
to heterogeneous mixtures and propose a two-step binding mechanism to describe how CTB 
binds to cell membrane glycolipids. We established a new technique to streamline the 
identification of glycolipids that only bind in mixtures and not by themselves. After establishing 
the basics of multivalent lectin binding and proposing a mechanism, we will apply these 
techniques to analyze LecA. In Chapter IV, we will establish LecA binding to homogeneous 
(individual glycolipid) and heterogeneous (mixed glycolipid) bilayers and demonstrate how the 
mechanism proposed in the study of CTB accurately predicts the data observed with LecA 
binding to glycolipids. Chapter V will introduce a TEA assay to assess lectin binding capacity. 
This assay will be compatible with high-throughput formation of the emulsion so that it can be 
used as a quick, semi-quantitative screen for changes in lectin binding. The results of the TEA 
assay will be confirmed using DLS to ensure that changes in turbidity are linked to actual droplet 
aggregation rates. A major benefit of this assay is that it eliminates the batch functionalization 
step required for nanocube binding studies in favor of potential continuous emulsion formation. 
In summary,wewill demonstrate the fundamentals of multivalent lectin binding in both CTB and 
LecA, propose and demonstrate the usefulness of a two-step binding mechanism in explaining 
multivalent lectin binding, and develop a TEA assay amenable to high-throughput emulsion 
formation and screening. 
 
*Reprinted with permission from “Binding cooperativity matters: A GM1-like 
ganglioside-cholera toxin B subunit binding study using a nanocube-based lipid bilayer array” by 
Worstell, Nolan C., Krishnan, Pratik, Weatherston, Joshua D., Wu, H. J., 2016, PLoS ONE, 11, 
Copyright 2016 by Public Library of Science 
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CHAPTER II  
BINDING COOPERATIVITY MATTERS: A GM1-LIKE GANGLIOSIDE-CHOLERA 
TOXIN SUBUNIT B BINDING STUDY USING A NANOCUBE-BASED LIPID BILAYER 
ARRAY* 
 
Chapter Summary 
Protein-glycan recognition is often mediated by multivalent binding. These multivalent 
bindings can be further complicated by cooperative interactions between glycans and individual 
glycan binding subunits. Here we have demonstrated a nanocube-based lipid bilayer array 
capable of quantitatively elucidating binding dissociation constants, maximum binding capacity, 
and binding cooperativity in a high-throughput format. Taking cholera toxin subunit B (CTB) as 
a model cooperativity system, we studied both GM1 and GM1-like gangliosides binding to CTB. 
We confirmed the previously observed CTB-GM1 positive cooperativity. Surprisingly, we 
demonstrated fucosyl-GM1 has approximately 7 times higher CTB binding capacity than GM1. 
In order to explain this phenomenon, we hypothesized that the reduced binding cooperativity of 
fucosyl-GM1 caused the increased binding capacity. This was unintuitive, as GM1 exhibited 
higher binding avidity (16 times lower dissociation constant). We confirmed the hypothesis 
using a theoretical stepwise binding model of CTB. Moreover, by taking a mixture of fucosyl-
GM1 and GM2, we observed the mild binding avidity fucosyl-GM1 activated GM2 receptors 
enhancing the binding capacity of the lipid bilayer surface. This was unexpected as GM2 
receptors have negligible binding avidity in pure GM2 bilayers. These discoveries demonstrate 
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the importance of binding cooperativity in multivalent binding mechanisms. Thus, quantitative 
analysis of multivalent protein-glycan interactions in heterogeneous glycan systems is of critical 
importance. Our user-friendly, robust, and high-throughput nanocube-based lipid bilayer array 
offers an attractive method for dissecting these complex mechanisms.  
Introduction 
Glycan binding proteins (GBPs) often recognize glycans present on cell surfaces via 
multivalent binding mechanisms. Many GBPs contain multiple glycan binding subunits that bind 
multiple glycans attached to lipids or membrane proteins on cell surfaces. These glycans can 
freely diffuse and rotate on a two-dimensional fluidic cell membrane, enabling self-organization 
for multivalent interactions with GBPs. Such multivalent interactions are mediated by 
cooperative effort between glycan-bound subunits that influence binding avidity and/or 
specificity.
14
 A good example of this cooperative binding is the interaction of cholera toxin 
subunit B (CTB) with gangliosides. CTB is a homopentamer that strongly associates with GM1 
gangliosides. Positive cooperativity between bound GM1 molecules can raise CTB-GM1 binding 
avidity by several orders of magnitude 
43,62
. The CTB-GM1 stepwise binding mechanism has 
been studied by isothermal titration calorimetry (ITC) and mass spectrometry (MS).
63,64
 In one 
study, Klassen and coworkers observed that the binding affinity (association constant) of the 
unbound subunit doubles in value when a bound GM1 is adjacent to the unbound pocket, 
demonstrating the positive cooperativity of GM1-CTB binding.
64
 Furthermore, this concept of 
binding cooperativity has been widely utilized to design high affinity inhibitors for various 
multivalent GBPs, including biotoxins and lectins.
26
 
Due to its high GM1 binding avidity, CTB has been widely used to monitor the quantity 
and localization of GM1 in cell staining.
65,66
 However, Yanagisawa et al. observed CTB could 
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bind to cell surfaces in the absence of GM1 gangliosides.
22
 They hypothesized that CTB binding 
to mouse embryonic neuroepithelial cells could be caused by the other GM1-like gangliosides, 
including fucosyl-GM1. However, the mechanism is not clear and requires additional cross-
reactivity data to elucidate. In order to quantify the cross-reactivity between CTB and mixed 
gangliosides, a high-throughput, easy-to-use, and robust analytical tool is of critical importance. 
A typical tool for glycan recognition is the glycan microarray where various synthetic or 
natural glycans are immobilized on a solid surface.
67,68
 In this technique, bound analytes are 
detected by labeling, such as fluorescent and immunostaining assays, or  by label-free detection 
technologies that require special instrumentation.
67
 A limitation of current glycan microarray 
technologies is the immobilization of glycan receptors onto the substrate.  This creates a problem 
because immobilized glycans cannot achieve optimal multivalent binding. It is impossible to 
control the spacing and orientation of glycans to match precisely the configuration of binding 
pockets in the target GBPs. Hence, the presentation of glycans on microarray surfaces, including 
linker effects and glycan density, influences GBP binding.
68
 This intrinsic drawback limits the 
ability of glycan microarrays to quantify the complex multivalent interactions. To overcome this 
drawback, an alternative approach is to insert glycans (e.g. glycolipids or neoglycolipids) into 
fluidic bilayers instead of immobilizing them onto a substrate.
63,69-72
 In a fluidic bilayer system, 
glycans can freely move and encounter target GBPs to enable multivalent interactions. Although 
the fluidic bilayer array format has been demonstrated by different research groups 
55,56,70,71,73
, 
none of these techniques has become wide spread throughout the biological sciences. This is 
probably due to a lack of accessibility and flexibility. 
To address the lack of accessibility and flexibility of prior systems, we introduced a 
unique nanocube sensor for direct measurements of CTB binding onto lipid bilayer surfaces.
74
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(Figure 1a) This Ag@SiO2 core-shell nanocube sensor enables label-free detection of protein 
binding to lipid bilayer surfaces by taking advantage of the fluidic bilayer system. To create the 
fluidic bilayer, a thin water layer mediates the supported lipid bilayer’s interaction with the 
sensor’s silica surface. This thin layer provides a flexible buffer that enables the bilayers to 
mimic an idealized cell membrane and possess similar two-dimensional fluidity.  Protein binding 
to lipid bilayers is monitored by observing the extinction spectra shift of the localized surface 
plasmon resonance (LSPR) using a standard UV\Vis spectrophotometer. Our previous study has 
demonstrated the application of this nanocube sensor.
74
 The advantages of this platform are (1) 
high accessibility (only requiring a standard spectrophotometer), (2) ease of use (a simple “mix-
and-then-detect” protocol), (3) high flexibility (allowing end users to build their own assays in-
house without special equipment), and (4) label-free detection. In contrast to conventional 
techniques that require labeling, this label-free sensor can directly quantify absolute surface 
densities of bound proteins without calibration prior to binding measurements. These outstanding 
features enable the quantitative analysis of GBP binding mechanisms. 
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Figure 1: Overview schematic of the nanocube-based sensor with confirmation by TEM 
(a) A schematic of the nanocube-based lipid bilayer array. Silica coated silver nanocubes 
(Ag@SiO2 nanocubes) are covered by a supported fluidic lipid bilayer that incorporates 
gangliosides. Equilibrium binding was detected in a 384 well plate by monitoring the 
extinction spectra in a microplate spectrophotometer. (b) A TEM image of the silica shell 
coated onto the Ag nanocubes. (c) A cryo-TEM image of the supported lipid bilayer coated 
onto the Ag@SiO2 nanocubes. Reprinted with permission from Worstell et al.
75
 
 
 
In this study, we improved the prior nanocube-based sensing platform to enable high-
throughput detection. We successfully achieved large-scaled synthesis of high quality nanocube 
sensors (one synthesis batch allowing up to 20,000 measurements), and adapted the sensors to a 
high-throughput microplate reader (384 well plate). This novel nanocube-based lipid bilayer 
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array allowed us to simultaneously perform many CTB binding measurements under different 
experimental conditions, facilitating the dissection of complex binding mechanisms. In this 
article, we measured the cross-reactivity of CTB with various gangliosides, including GM1, 
GM2, and fucosyl-GM1. We observed approximately 7 times higher CTB binding capacity on 
the fucosyl-GM1 surface than the GM1 surface. This was unexpected, as GM1 is known to 
exhibit higher binding avidity (i.e. lower dissociation constant). Moreover, we observed the very 
weak binding receptor, GM2, was activated by fucosyl-GM1. This activation increased the 
number of CTB molecules binding to the fucosyl-GM1-GM2 lipid bilayer. To the best of our 
knowledge, these phenomena have never been reported. To explore the observed phenomena 
theoretically, we analyzed the stepwise binding model reported by Klassen and his coworkers 
64
. 
From probing Klassen’s model, we found binding cooperativity plays an essential role in CTB 
binding. This analysis may answer the question posed by Yanagisawa et al., “why is the amount 
of bound CTB not correlated with the GM1 expression level in neural cells?” 22. Our discovery 
demonstrates the essential nature of cooperativity in multivalent GBP binding. Furthermore, our 
sensor provides a facile method to analyze GBP cooperativity as its fluidic bilayer provides 
unconstrained binding for CTB and its high-throughput methodology enables the study of cross-
reactivity. By leveraging our nanocube-based lipid bilayer array, we can assist biologists in 
dissecting the complex binding mechanisms of multivalent GBPs. 
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Materials and Methods 
Materials 
Monosialoganglioside, GM1, (2Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc-
Ceramide) was acquired from three different vendors, including Matreya LLC (State College, 
PA), Avanti Polar Lipids (Alabaster, AL), and Sigma-Aldrich. Fucosylated 
monosialoganglioside GM1 (Fucα1-2Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc-Ceramide, 
fucosyl-GM1), was purchased from Matreya LLC. 1, 2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), 1, 2-dioleoyl-sn-glycero-3-phospho-L-serine - sodium salt (DOPS) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(biotinyl) (biotin-PE) were obtained from Avanti Polar 
Lipids (Alabaster, AL). Cholera Toxin subunit B (CTB) from Vibrio cholerae, GM2 
(3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc-Ceramide), streptavidin from Streptomyces avidinii 
(StP), copper (II) chloride dihydrate, polyvinylpyrrolidone (PVP) (MW ~55,000), tetraethyl 
orthosilicate (TEOS), and silicone oil (useable range -50
o
C to +200
o
C) were purchased from 
Sigma-Aldrich. Silver nitrate (Premion, 99.9995%) was purchased from Alfa-Aesar. 1,5-
Pentanediol 98% (PD) was purchased from Acros Organics through Fisher Scientific. The 
calibration experiments were performed in 1X phosphate buffered saline (PBS) solution diluted 
from a 10X PBS stock from CulGenX. CTB binding was performed in 1X Tris-buffered saline 
(TBS) solution (20mM Tris 0.9% NaCl pH~7.4) diluted from a 10X TBS stock from Sigma-
Aldrich. 
Methods 
Silver nanocube synthesis procedure 
The nanocube synthesis procedure was taken from Tao et al.
76
 The procedure was based 
on the polyol method and described in brief as follows. First, 0.2 g of PVP was dissolved into 10 
 16 
 
mL of PD. Next, 0.2 g of AgNO3 was dissolved into 10 mL of PD with 30 µL of a 0.082 g/mL 
CuCl2 in PD solution. Then, 20 mL of PD was heated in a 190 
°
C silicone oil bath. After the PD 
was heated sufficiently, 500 L of the AgNO3 solution and 500 μL of the PVP solution were 
added sequentially every minute. This was continued until all 10 mL of both the AgNO3 and 
PVP solutions were added. When finished, the nanocubes were washed with 200 proof ethanol 
using a centrifuge.  
Modified nanocube silica coating procedure 
Our silica coating procedure was adapted from Wu et al. with a few alterations and 
presented with alterations as follows.
74
 To improve silica shell quality in the scaled-up synthesis 
batch, the silica coating reaction was conducted in 2-propanol, instead of ethanol. 20 mL of stock 
silver nanocubes stored in ethanol was first transferred into 2-propanol. Then, the  silver 
nanocube solution was suspended into 55 mL of 2-propanol and mixed with 22.1 mL of water, 
6.80 mL of TEOS, and 3.4 mL of 0.84 w/v% ammonium hydroxide solution. Next, the solution 
was stirred at room temperature for 80 minutes. After the reaction finished, 50 mL of ethanol 
were added to quench the reaction. The resultant particles were washed with Milli-Q
®
 water a 
few times, and stored in Milli-Q
®
 water for future use. (Figure 1b) 
Calibration of the silica coated silver nanocubes 
The thickness of the silica coated onto the silver nanocube was imaged directly using a 
transmission electron microscope (FEI Technai G2 F20 FE-TEM). The size and uniformity of 
the silver nanocubes prior to silica coating was determined by direct imaging with a scanning 
electron microscope (FEI Quanta 600 FE-SEM). The sensitivity of the silica coated silver 
nanocubes was determined by the method given by Wu et al. using a figure of merit (FOM) that 
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was calculated by dividing refractive index sensitivity by the line width of the resonance 
spectrum.
74
  
The relationship between the quadrupole LSPR peak shift and the surface mass density of 
protein bound was measured by binding streptavidin to biotin-PE on the bilayer surface. 
74
 
(Figure 22) Our previous work established a protocol to change bound streptavidin by titrating 
streptavidin concentration.
74
 Briefly, bilayer (89 mol% DOPC/10 mol% DOPS/1 mol% biotin-
PE) coated Ag@SiO2 nanocubes were titrated with streptavidin in a 384 well plate (Greiner Bio-
one). The average streptavidin surface density on the nanocubes was evaluated by approximating 
each lipid as a single DOPC lipid to obtain the surface area coverage in the supported bilayers.
74
 
Supported bilayer preparation 
Small unilamellar vesicles (SUVs) were prepared as follows. The desired composition of 
lipids in chloroform was mixed and then dried using a rotary evaporator (Heidolph Hei-VAP 
Value
®
). Then, the dried lipids were rehydrated with Milli-Q
®
 water and extruded through 100 
nm polycarbonate filters (Whatman
®
) using a Mini-extruder (Avanti Polar Lipids) to achieve an 
extruded lipid concentration of 3 mg/mL. Supported lipid bilayers were formed by a modified 
vesicle-fusion technique. In this technique, Ag@SiO2 nanocubes were sequentially added into a 
SUV solution with a high SUV concentration in the initial coating solution. Briefly, 10 µL of 
nanocube solution and 30 µL of 2X TBS buffer were added to 20 µL of concentrated SUV 
solution (3 mg/mL) followed by 10 seconds of sonication in a bath sonicator (Branson). Then, 10 
µL of the nanocube solution and 10 µL of 2X TBS buffer were added followed by 10 seconds of 
sonication. This process was repeated until all of the nanocube solution had been added. After 
coating the supported bilayer, additional TBS buffer was added to the solution to reach the 
desired concentration of salt (1X TBS), SUV’s, and nanocubes in the final solution.  
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Protein binding measurement 
Bilayer coated nanocubes were incubated with the desired protein concentration in a 384 
well plate for 1.5 hours. Blank solutions were prepared for each CTB concentration by mixing 
buffer, SUVs, and CTB corresponding to that composition. Next, the 384 well plate was placed 
in a vacuum chamber at 40 cm Hg of vacuum for 15 minutes to remove air bubbles before 
collecting extinction spectra with a UV/Vis microplate spectrophotometer equipped with a CCD 
(FLUOstar Omega
®
, BMG-Labtech). The location of the quadrupole LSPR peak was detected by 
fitting a seventh order polynomial to the spectrum. The fitted spectrum resulted from averaging 
200 flashes per well at a 1 nm spectral resolution; the scanning rate for each well was less than 1 
second. All experiments were performed at room temperature. 
The total amount of the CTB was calculated from the amount of CTB added. The amount 
of bound CTB was calculated from the observed LSPR shifts. The individual replicate LSPR 
shift was obtained by finding the wavelength corresponding to the maximum absorbance given 
by the seventh order polynomial peak fitting. Then the LSPR shifts of eight replicate wells were 
averaged to give the observed LSPR shift used to calculate the amount of bound CTB based on 
the streptavidin-biotin binding calibration. The difference between the total amount of CTB and 
the amount of bound CTB gave the amount of unbound CTB.  
Cryo-TEM measurements 
Supported lipid bilayer morphology and quality was assessed by cryo-TEM (FEI Technai 
G2 F20 FE-TEM with a Gatan Tridiem
®
 GIF-CCD using a Gatan 626 cryo-specimen holder) 
(Figure 1c). Measurements were conducted on silica-coated silver nanoparticles supporting 88 
mol%-90 mol% DOPC/10 mol%DOPS/0-2 mol% ganglioside lipid bilayers. The lipid bilayers 
were coated 1 hour before vitrification and stored in a 1X TBS buffer. The samples were vitrified 
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on Quantifoil
®
 grids, with holey carbon films (shape R2/2); the sample, suspended in 1X TBS 
aqueous solution, was rapidly frozen via submersion in liquid ethane and cooled to liquid 
nitrogen temperature using an FEI Vitrobot
®
.  
Simulation of localized surface plasmon resonance (LSPR) 
To simulate the electric field environment near a single silica-coated silver nanocube, the 
observed particle geometry (from TEM) was used to construct a Finite Element Method (FEM) 
model in the COMSOL Multiphysics RF Module
®
. We simulated a quarter cube of side length 
112 nm, radius of curvature 12 nm, and silica shell thickness of 4 nm on the sides smoothly 
transitioning to 3.1 nm on the corners, oriented such that symmetry was imposed in the planes 
perpendicular to the x and y axes. A plane wave, propagating in the +x direction and polarized 
along the z-axis, was introduced and then Maxwell’s equations were solved for the resulting 
scattered electric field. The extinction coefficient, which is equal to the extinction spectrum 
when scaled by path length and particle concentration, was calculated from the scattered field. 
The simulation was repeated, varying dielectric properties of the model environment, until the 
refractive index sensitivity calibration experiment was repeated in silico.  
Statistical analysis and regression 
Each data point of each binding curve is represented as the mean ± standard deviation 
(S.D.) where n=8. Then, the Hill-Waud model was fit to the binding curves. To fit the Hill-Waud 
model to our data, we used the Levenberg Marquardt iterative algorithm (fitnlm function in 
Matlab 2013b
®
). The choice of the Levenberg Marquardt function was based on fitting a 
relatively simple function, desiring fast solution times, and having very precise instrument 
measurements of the wavelength. The fitnlm function returned the calculated value, standard 
error, and R
2
 value presented for each variable in Table 1. 
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Results 
Scaled-up Synthesis of Ag@SiO2 Nanocubes for High-Throughput Detection 
Analysis of multivalent ganglioside-CTB interactions required many measurements under 
different experimental conditions with replication. Therefore, large-scale synthesis of high 
quality sensors was critical to perform the analysis. The current silver nanocube synthesis is 
large-scale (allowing up to 20,000 measurements per batch); however, the silica coating process 
remained at a smaller scale (<5mL batch reactor). The prior protocol required extensive 
sonication throughout the reaction. However, it was difficult to provide sufficient mixing power 
in a large batch reactor by sonication. To scale up Ag@SiO2 synthesis, we modified the prior 
Stӧber silica coating procedures.74 Instead of ethanol, 2-propanol was used in the silica coating 
reaction to increase the hydrolysis reaction rate of TEOS.
77
 This was necessary as ammonium 
hydroxide forms an ammonium silver complex that prevents the formation of the SiO2 shell.
78
 
Hence, the hydrolysis reaction rate was increased to be competitive with the formation of the 
ammonium silver complex and improve SiO2 shell uniformity. In addition to preventing SiO2 
shell formation, the ammonium silver complex occurs preferentially at the exposed [111] crystal 
plane resulting in etching. The localization of the ammonium silver complex formation is due to 
the strong adsorption of PVP on [100] facets that prevents/slows the reaction between the silver 
and ammonium ions.
79
 Problematically, etching by the ammonium silver complex results in 
rounded nanocube corners, reducing electro-magnetic field enhancement and lowering sensor 
sensitivity. Thus, the increased hydrolysis rate minimized these drawbacks and improved the 
quality of silica coating in the scaled-up synthesis. (Figure 21) 
The quality of Ag@SiO2 nanocubes was determined by TEM. (Figure 1b and Figure 
21) The refractive index sensitivity of the Ag@SiO2 sensor was measured by suspending the 
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sensor in various glycerol-water solutions. (Figure 2) In order to confirm the variation of the 
Ag@SiO2 nanocubes, we modeled the LSPR of the Ag@SiO2 nanocubes based on their 
geometry observed in TEM images (averaged length 112 nm and corner curvature 12 nm). In 
Figure 2, the experimental sensitivity has been compared with the LSPR simulation. The 
refractive index sensitivity of the single simulated cube (254±9 nm/RI, mean ± S.E., n=5) was 
observed to be very similar to the ensemble average of the experimental response (242±4 nm/RI, 
mean ± S.E., n=20). This simulation result suggested that our nanocube synthesis yielded high 
quality nanoparticles with low polydispersity.  
After characterization of Ag@SiO2, the cubes were covered with a supported lipid bilayer 
and characterized again. Supported lipid bilayer morphology and quality was imaged by cryo-
TEM. (Figure 1c) The Ag@SiO2 nanocube was uniformly covered by a continuous supported 
lipid bilayer with approximately 4nm thickness, which is similar to the known thickness of a 
lipid bilayer 
80
.  
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Figure 2: High quality nanocube synthesis and sensor sensitivity confirmed with single 
particle computational modeling. Refractive Index (RI) vs. change in quadrupole LSPR 
peak location using a single Ag@SiO2 nanocube simulated in COMSOL Multiphysics and 
using Ag@SiO2 nanocubes in various glycerol-water mixtures measured with a 
spectrophotometer. The experimental slope is 242 nm/RI unit ±4 (S.E. of the estimate, n=20). 
The computational slope is 254 nm/RI ± 9 (S.E., n=5). The details are in the Chapter II 
Methods Section. (Inset) A computational model of a single Ag@SiO2 nanocube that was 
simulated in COMSOL Multiphysics® using the Radio Frequency module. Reprinted with 
permission from Worstell et al.
75
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Multivalent Binding Between CTB and GM1 Ganglioside 
Cholera toxin subunit B (CTB) binding to the lipid bilayer was measured by observing 
the shift of the quadrupole LSPR scattering peak of our nanocube based sensor. All 
measurements were conducted with eight replicates for each protein concentration in a 384 well 
plate using a high-throughput microplate reader. We followed the protocol reported by Wu et al. 
to calibrate the correlation between the quadrupole LSPR shift and the protein density by 
titrating bound streptavidin onto the lipid bilayer containing biotin-PE.
74
 (Figure 22) This 
correlation allowed quantification of an absolute bound CTB density on ganglioside presenting 
surfaces. Control experiments were also carried out on the lipid bilayer with 90 mol% DOPC and 
10 mol% DOPS. 
To measure the cooperativity of multivalent CTB binding, a classic multivalent binding 
model, the Hill-Waud binding model (Equation 1), was used to fit the equilibrium binding 
curves.
81
 
Equation 1 
𝐶 =
𝐶𝑚𝑎𝑥[𝑃]
𝑛
𝐾ℎ
𝑛 + [𝑃]𝑛
 
C is the concentration of bound CTB to the cell membrane surface and [P] is the concentration of 
unbound CTB in the solution. The fitted parameters are: Cmax, the maximum binding capacity of 
membrane surface; Kh, the apparent dissociation constant; and n, the Hill coefficient of 
cooperativity. If there was no cooperativity between two bound gangliosides, n was equal to one. 
When n was larger or smaller than one, it represented positive or negative cooperativity, 
respectively.  
 24 
 
 
Figure 3: Equilibrium binding data for CTB binding with different gangliosides. The 
insets represent the same binding curves on semi-log scale to better show the data points at 
low concentrations. (a) CTB-GM1 binding data under differing surface densities. (b) 
Homogeneous receptor CTB-(GM1-like) ganglioside binding data with constant surface 
density. (c) CTB-fucosyl-GM1 & CTB-GM2 binding data under differing surface densities. 
(d) Heterogeneous CTB-ganglioside mixture binding data at constant surface density. A 
control of 90 mol% DOPC/ 10 mol% DOPS was used to verify the absence of non-specific 
binding. Data points are reported as mean ± S.D (n=8). Reprinted with permission from 
Worstell et al.
75
 
 
 
In the GM1 binding experiments, the nanocube sensors were coated with lipid bilayers 
containing various surface densities of GM1 (1, 2, 4, and 10 mol%) separately for CTB binding. 
The binding curves were measured by titrating CTB in separate wells of a 384 well plate, with 8 
replicates per titration, at each mol% GM1 (Figure 3a). The CTB-GM1 binding system provided 
a good comparison for our nanocube sensor with other established methods because its binding 
mechanism has been well studied.
63,69,81-85
 The fitted parameters of the Hill-Waud equation are 
shown in Table 1. Intuitively, increasing GM1 density increased the binding capacity (Cmax) of 
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the bilayer surfaces. We also observed that the Kh of CTB-GM1 binding increased with 
increasing GM1 mol%. Furthermore, Cremer and his coworkers observed the same phenomena 
on supported lipid bilayers using fluorescent microscopy.
81,82
 They suggested the clustering 
effect of gangliosides in supported lipid bilayers at higher surface densities inhibits CTB 
binding.
82
 In addition, the positive cooperativity of CTB-GM1 binding was observed from the 
fitted Hill’s coefficients (n), and the measured coefficients were similar to the values reported in 
literature.
81,82
 
Table 1: Hill-Waud Equation Fitting Parameters for various ganglioside compositions. 
Reprinted with permission from Worstell et al.
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Lipid composition (mol %) Hill's equation fitting parameters 
DOPC% DOPS% GM1% 
fucosyl-
GM1% 
GM2% 
Kh±S.E. of the 
estimate 
(n=19) (nM) 
Cmax ±S.E. 
of the 
estimate 
(n=19) 
(nM) 
n ±S.E. of the 
estimate(n=19) 
R
2
 
89 10 1 0 0 5.6 + 0.6 5.3 + 0.1 2.25 + 0.45 0.943 
88 10 2 0 0 14.5 + 1.0 11.5 + 0.3 1.93 + 0.25 0.968 
86 10 4 0 0 48.0 + 3.0 41.0 + 1.8 2.79 + 0.45 0.959 
80 10 10 0 0 151.0 + 7.0 79.0 + 2.3 2.79 + 0.31 0.986 
89.5 10 0 0.5 0 59.4 + 5.7 12.0 + 0.3 0.78 + 0.05 0.993 
89 10 0 1 0 270.8 + 56.8 32.5 + 1.9 0.69 + 0.06 0.992 
88.5 10 0 1.5 0 129.1 + 13.0 34.4 + 1.1 1.06 + 0.09 0.989 
88 10 0 2 0 251.8 + 47.1 83.5 + 5.3 0.89 + 0.10 0.985 
88 10 0 0.5 1.5 563.4 + 156.4 88.7 + 8.5 0.85 + 0.11 0.982 
88 10 0 0.75 1.25 380.4 + 159.1 91.0 + 9.1 0.56 + 0.07 0.978 
88 10 0 1 1 830.5 +114.6 96.6  +4.9 0.82 +0.04 0.998 
88 10 0 1.5 0.5 682.7 + 190.5 92.6 + 7.9 0.69 + 0.05 0.993 
 
 
Multivalent Binding Between CTB and GM1-Like Gangliosides 
Beyond GM1, other GM1-like gangliosides associated with CTB have been identified. 
Most of the previous studies identified GM1- and GM1-like ganglioside-CTB binding avidities 
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with isothermal titration calorimetry (ITC), mass spectrometry (MS), or immobilized receptors 
on solid substrates.
62-64,83,84,86
 Some studies conducted the CTB-ganglioside binding 
measurements using fluidic lipid bilayers.
44,69,72,81,82,85,87-89
 Regardless of measurement technique, 
these studies often reported the apparent association constants and thermodynamic parameters of 
CTB binding to various gangliosides, but few of them analyzed the cooperative actions between 
bound gangliosides. To further investigate cooperative interaction in multivalent CTB binding to 
GM1-like gangliosides, we selected two gangliosides, fucosyl-GM1 and GM2, which exhibit 
mild and weak binding avidity to CTB, respectively.  
Masserini et al. 
89
 and Iwabuchi et al. 
90
 found the binding association constants of CTB 
with fucosyl-GM1 or GM1 ganglioside were comparable. Several studies reported diverse 
association binding constants of CTB with GM2, but the binding avidity of GM2 was generally 
much lower (10~10
5
 times weaker) than GM1.
62,83,84,86
 To investigate the multivalent binding of 
these two gangliosides, we measured the binding curves at 2 mol% surface density of each 
ganglioside and fitted the Hill-Waud equation to the curves. (Figure 3b and Table 1) The Kh of 
fucosyl-GM1 was approximately one order of magnitude higher than GM1. A very weak binding 
of CTB to GM2 was observed. However, we did not reach the plateau region for the GM2 
binding curve, as the concentration of CTB was far beyond physiologically relevant conditions.
91
 
Regardless, this low binding avidity was not surprising because Lauer et al. and MacKenzie et al. 
could not detect any binding of CTB to fluidic bilayer surfaces with GM2 receptors.
69,85
 
We observed the Hill coefficient is usually less than one for fucosyl-GM1, even when 
accounting for the standard error of the estimate.  This indicated that the interaction between 
bound fucosyl-GM1 and its free counterpart is negatively cooperative. This implies the initially 
bound receptor lowers the binding avidity for future binding events.  The fitted parameters, Kh 
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and Cmax, of the GM2 binding curve were not very accurate as these two parameters depend 
highly on the plateau region of the binding curves. The lower CTB concentration range mainly 
determined the fitting of n value; hence, the negative cooperativity of GM2 binding was still 
convincing (n=0.70±0.04, mean ± S.E., n=19). To the best of our knowledge, such negative 
cooperativity of CTB with GM1-like gangliosides has not yet been reported.  
The most surprising observation was that the binding capacity (Cmax) of fucosyl-GM1 
was more than 7 times greater than GM1 at the same surface density (2 mol%). This contrasted 
with the dissociation constant of GM1, which was more than 16 times lower. To exclude 
experimental error from degradation of GM1 reagents, we performed the same binding 
measurements with GM1 gangliosides acquired from three different vendors (Sigma-Aldrich, 
Avanti, and Matreya LLC). The binding curves of the three GM1 gangliosides across eight 
replicates were very consistent. (Figure 23) These experiments demonstrated that the 
degradation of GM1 reagent was not the cause of the lower binding capacity of the CTB- GM1 
binding system. These data sets also indicated that the experimental variation of our binding 
measurements was low. The GM1 used for all the other experiments was obtained from Matreya 
LLC. 
The Influence of Cooperativity on Binding Capacity 
To the best of our knowledge, the unusually high binding capacity observed for fucosyl-
GM1 has not been reported. Based on the fitting of the Hill-Waud model, we found that the 
major difference between GM1 and fucosyl-GM1 was the Hill coefficient of cooperativity, n. 
We suspected the reduced cooperativity of fucosyl-GM1 binding led to the higher observed 
binding capacity. To understand the binding mechanism, we explored a stepwise binding 
mechanism of CTB. Klassen and his coworkers used direct electrospray ionization mass 
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spectrometry (ESI-MS) to investigate the stepwise binding of GM1 to CTB. 
64
 They established 
a comprehensive stepwise binding model  (Figure 24) and determined the apparent association 
constants for three different states (K1, K2, K3), including zero, one, or two receptor-bound 
nearest neighbors.
64
 The binding affinity was enhanced by a factor of approximately two when 
there was a bound GM1 next to the binding pockets. This comprehensive, single receptor binding 
model allowed us to explore the detailed binding mechanism by calculating the concentration of 
each binding state. 
We modeled Klassen’s stepwise binding and calculated the concentration of each CTB-
GM1 bound state under different CTB concentrations. The equation we adapted from Klassen’s 
model is summarized in APPENDIX A. The association constants of fucosyl-GM1 for each 
individual state were not measured, so we added a factor ‘α’ to estimate, from initial binding 
(K1), the affinity of the CTB binding subunit when there are one (K2 ) or two (K3) bound 
gangliosides as the nearest neighbors. α > 1 represented positively cooperative binding and α < 1 
represented negatively cooperative binding. Using the empirical values obtained by Klassen et 
al., α ≈ 2 for GM1, indicating positive cooperativity. This theoretical model demonstrated that 
receptors with reduced cooperativity compared with GM1 (α < 2) could reach a higher binding 
capacity than GM1 (α~2), despite having the same initial binding affinity (K1). (Figure 4a)   
Since the overall Kd was higher for fucosyl-GM1 (Table 1), it was reasonable to conclude that 
K1 of fucosyl-GM1 would be less than the K1 for GM1. To reflect this qualitatively, we changed 
the value of K1 to half of its original value to see if that altered our observation. (Figure 25) 
Despite this change, we observed that the binding capacity continued to be higher for receptors 
with lower cooperativity.  To understand this unusual behavior, we calculated the concentration 
of CTB in each bound CTB state. (Figure 26) We found the model predicted that the number of 
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CTB molecules binding with two or more gangliosides was higher when the binding 
cooperativity was positive. For positive cooperativity, the bound gangliosides enhanced the 
binding affinity of unbound binding subunits, making the second and higher order binding events 
more favorable. In contrast, the average number of lipids per CTB was closer to one when the 
binding was negatively cooperative. As shown in plotted model data in Figure 4b, the average 
number of bound ganglioside receptors per CTB increased when cooperativity increased. This 
meant that the model predicted a single CTB bound more gangliosides and reduced the number 
of free gangliosides available on the lipid bilayer during positively cooperative binding. 
Therefore, the total binding capacity of positive cooperative binding was lower. Recently, 
Klassen and his coworkers reported a similar phenomenon using nanodisc-ESI-MS technology.
72
 
They found that the majority of CTB molecules bound to only one ganglioside when three 
gangliosides, GM1, GM2, and GM3, were incorporated in separate nanodiscs. If three 
gangliosides were mixed in a single nanodisc, most CTBs bound to two gangliosides. We believe 
the reduced cooperativity, relative to GM1, of GM1-like gangliosides led to their experimental 
findings. Our theoretical analysis of the stepwise binding model has demonstrated that 
cooperativity significantly influences binding capacity. Thus, the unusually high binding 
capacity of fucosyl-GM1 might be attributed to its lower cooperativity.  
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Figure 4: Simulated binding with varying cooperativity based on Klassen’s theoretical 
model. (a) Total bound CTB as a function of unbound CTB for varying cooperativity ratios. 
The negative cooperativity (α = ½ ) could reach a higher binding capacity than GM1 (α ~ 2) 
(b) Bound CTB and average number of ganglioside receptors per bound CTB molecule as a 
function of the affinity scaling factor, α, with an unbound CTB concentration of 500 nM. 
Reprinted with permission from Worstell et al.
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The Influence of Mixed Gangliosides on Multivalent Binding 
After demonstrating that cooperative interaction between molecules of a single 
ganglioside type significantly influences multivalent binding, we hypothesized that cooperative 
interaction between heterogeneous gangliosides might also play an essential role in CTB binding 
mechanisms. In order to test this hypothesis, we mixed weak and mild binding gangliosides, 
GM2 and fucosyl-GM1, under different surface densities to investigate their cooperative 
interactions. The total surface density of GM2 and fucosyl-GM1 was fixed at 2 mol% and we 
varied the ratio of these two gangliosides (0.5 mol%/1.5 mol%, 0.75 mol%/1.25 mol%, 1 
mol%/1 mol%, and 1.5 mol %/0.5 mol % of GM2/fucosyl-GM1). For comparison, we also 
measured the binding curve of individual fucosyl-GM1 at 0.5, 1.0, 1.5, and 2.0 mol% surface 
density. The binding curves and the fitted Hill-Waud parameters were recorded in Figure 3b and 
Table 1. It is important to recognize that the Kh and n values do not carry the same physical 
meaning when commuted to the two-component binding model. This is because the Hill-Waud 
model was derived from single-receptor system (hemoglobin-oxygen binding). This means that a 
two-component fitted Hill-Waud model is an empirical model. Thus, Kh and n values must be 
considered apparent terms representing the combined effects of the two components; this limits 
any conclusions that could be drawn from a thermodynamic analysis of the fitted model. Due to 
these limitations, we do not refer to Cmax when referencing the two-component system, but rather 
refer to the binding capacity observed at the highest tested concentration, 3.4 µM unbound CTB 
(C3.4µM). By this measure, we can draw direct comparisons to the pure component systems. 
As expected, without GM2, reducing fucosyl-GM1 surface density on the membrane 
surface reduced the maximum binding capacity (Cmax). The dissociation constant also decreased 
at lower fucosyl-GM1 surface density. The same trend was observed in our GM1 measurements 
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and the GM1 measurements reported by Cremer and his coworkers.
81
 Interestingly, the 
additional GM2 gangliosides compensated for the loss of fucosyl-GM1 (for the tested conditions) 
and the highest observed CTB binding (C3.4µM) for GM2/fucosyl-GM1 mixtures reached values 
similar to C3.4µM for 2 mol% fucosyl-GM1. If CTB binding to GM2 and fucosyl-GM1 were 
independent, the C3.4µM for GM2/fucosyl-GM1 mixtures should equal the sum of the C3.4µM 
values for equivalent single-receptor bilayers containing GM2 or fucosyl-GM1. This is not the 
case. For instance, the total bound CTB at 3.4µM (C3.4µM) on 1.5 mol% GM2/ 0.5 mol% fucosyl-
GM1 surface is approximately 7 times higher than the summation of pure component systems. 
These data sets suggested the multivalent binding depends on the complex pattern of 
gangliosides. 
Discussion 
We performed direct measurements to demonstrate the essential nature of binding 
cooperativity in pentavalent CTB binding to gangliosides on lipid bilayer surfaces. Our stepwise 
reaction analysis confirmed the higher binding capacity of fucosyl-GM1 compared to GM1, and 
suggested that this might be induced by the reduced binding cooperativity of fucosyl-GM1. The 
observed binding capacity (C3.4µM) of the membrane with the GM2/fucosyl-GM1 mixture also 
markedly increased compared to the summed total binding capacity of equivalent membranes 
with a single type of ganglioside. This change may indicate a conformational change induced by 
either fucosyl-GM1 or GM2 to alter binding preferences and/or inter-subunit distances. The 
other possible explanation is the reduction in membrane fluidity, which can improve CTB 
binding as observed by Terrell et al.
88
 However, this seems less likely than cooperative 
interactions between fucosyl-GM1 and GM2 because the total ganglioside surface density was 
maintained at 2 mol% and both gangliosides have very similar molecular structures. Thus while 
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we cannot identify the exact mechanism, we are reasonably certain that cooperativity between 
fucosyl-GM1 and GM2 can significantly enhance the bound CTB concentration.  
Biologists have also observed unexpected binding between CTB and mixed 
gangliosides.
22,23,92
 In the past, CTB has been used to quantify the amount of GM1 that was 
present in a cell membrane 
23,93
, but the validity of this approach was refuted by Yanagisawa et 
al.
22
  In the absence of GM1, Yanagisawa et al. observed strong reactivity between CTB and 
embryonic neuroepithelial cells and attributed this phenomenon to the expression of GM1- like 
ganglioside.
22
 More recently, some studies have used local CTB concentration differences as a 
means to identify and/or quantify lipid rafts.
94,95
 However, it was recommended that this 
approach be combined with other methods before asserting the presence of lipid rafts based on 
CTB binding to multiple gangliosides.
23,90
 Thus, for CTB to be used in quantification and/or 
identification of GM1, the analysis must be combined with another analysis method, such as 
MS/MS or ITC, or a tool that can differentiate between binding of CTB to different gangliosides 
and account for cooperativity. 
Similar cooperativity may appear in the other multivalent GBPs (e.g. lectins). Lectins, 
often consisting of multiple identical binding subunits, are widely used in glycomic analysis (e.g. 
lectin microarray or cell staining).
19,96-98
 From conventional glycoarray analysis, it is known that 
some lectins preferentially bind to the same glycan structure; however, their binding specificities 
to a heterogeneous cell surface are very different. For instance, Gal-GalNAc is the preferred 
glycan binding structure for Amaranthus caudatus lectin, Agaricus bisporus lectin, Colchicum 
autumnale lectin, Maackia Amurensis lectin I, and Phytolacca americana lectin, but these lectins 
exhibited varying binding specificities to different types of cells.
96
 We hypothesize the 
cooperative efforts among heterogeneous glycans may contribute to lectin binding specificities. 
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Hence, in order to understand hetero-multivalent binding, a new analytical tool is of critical 
importance. 
Cooperative binding between heterogeneous glycan structures is difficult to observe by 
conventional glycan microarray analysis because glycan microarrays often detect only the 
interactions with isolated glycans. Although some studies have printed mixed glycans on solid 
substrates
35,36
, immobilized glycans cannot achieve optimal multivalent binding with proteins. 
Therefore, there is a need for our nanocube-based sensor with gangliosides inserted into a fluidic 
supported lipid bilayer that enables the detection of hetero-multivalent binding. Combined with 
glycolipid synthesis, such as neoglycolipid (NGL) technology
99
, the nanocube-based lipid bilayer 
array can be an attractive tool for studying GBP-glycan recognition.  
Our sensing platform greatly improves on traditional methods by taking advantage of 
supported lipid bilayer technology. Our platform is also an improvement on current fluidic 
bilayer methods in several ways. First, our nanocube-based sensor is inexpensive. Second, our 
assay is compatible with high-throughput analysis methods, allowing thorough study of complex 
binding systems. Third, our nanocube-based lipid bilayer array is compatible with common 
laboratory equipment, enabling widespread use while still maintaining sensitivity.  
Chapter Conclusion 
Using our nanocube-based system, we were able to experimentally elucidate the 
relationship between cooperativity and maximum CTB-ganglioside binding and the effects of 
mixing multiple recognized gangliosides in a single lipid bilayer system. Through experimental 
measurements and representative stepwise binding analysis, we demonstrated that binding 
cooperativity is essential in multivalent CTB binding. The attenuation or enhancement of CTB 
binding was shown not to simply be controlled by any one of the gangliosides; the reactivity 
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depended on cooperative interactions within the entire ganglioside complex. This analysis 
required many replicates and individual experimental conditions, despite only analyzing a single 
two component cross-reactivity test. We were able to obtain all of these data with replicates 
because of our highly accessible and high-throughput nanocube-based lipid bilayer array that can 
be leveraged by biological communities to dissect additional complex binding models of 
multivalent binding proteins. 
 
*Reprinted with permission from “Hetero-multivalent Binding of Cholera Toxin Subunit 
B with Glycolipid Mixtures” by Krishnan, Pratik, Singla, Akshi, Lee, Chin-An, Weatherston, 
Joshua D., Worstell, Nolan C., Wu, Hung-Jen, 2017, Colloids and Surfaces B: Biointerfaces, 
160,281-288, Copyright 2017 by Elsevier B.V. 
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CHAPTER III  
HETERO-MULTIVALENT BINDING OF CHOLERA TOXIN SUBUNIT B WITH 
GLYCOLIPID MIXTURES* 
 
Chapter Summary 
GM1 has generally been considered as the major receptor that binds to cholera toxin 
subunit B (CTB) due to its low dissociation constant. However, using a unique nanocube sensor 
technology, we have shown that CTB can also bind to other glycolipid receptors, fucosyl-GM1 
and GD1b. Additionally, we have demonstrated that GM2 can contribute to CTB binding if 
present in a glycolipid mixture with a strongly binding receptor (GM1/fucosyl-GM1/GD1b). 
This hetero-multivalent binding result was unintuitive because the interaction between CTB and 
pure GM2 is negligible. We hypothesized that the reduced dimensionality of CTB-GM2 binding 
events is a major cause of the observed CTB binding enhancement. Once CTB has attached to a 
strong receptor, subsequent binding events are confined to a two-dimensional membrane surface. 
Therefore, even a weak GM2 receptor could participate in second or higher order binding events 
because its surface reaction rate can be up to 10
4
 times higher than the bulk reaction rate. To test 
this hypothesis, we altered the surface reaction rate by modulating the fluidity and heterogeneity 
of the model membrane. Decreasing membrane fluidity reduced the binding cooperativity 
between GM2 and a strong receptor. Our findings indicated a new protein-receptor binding 
assay, that can mimic the complex cell membrane environment more accurately, can be used to 
explore the inherent hetero-multivalency of the cell membrane. We have thus developed a new 
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membrane perturbation protocol to efficiently screen receptor candidates involved in hetero-
multivalent protein binding. 
Introduction 
Many proteins recognize glycolipid receptors in cell membranes via multivalent binding 
mechanisms.
13
  Such dynamic binding, driven by a series of binding domains, brings a protein to 
a membrane surface and initiates biological processes. Interactions between a single glycolipid 
receptor and a protein binding subunit are often weak, and therefore multivalency enhances the 
protein binding avidity and specificity to cell surfaces. Cholera toxin (CTx), the virulence factor 
of Vibrio cholerae, is a type of multivalent glycolipid binding protein. This AB5 toxin consists of 
a single A subunit associated with five identical B subunits. The B pentamer binds to cell 
membranes and delivers the catalytic A subunit into the cytoplasm. A potential stepwise reaction 
of pentavalent cholera toxin subunit B (CTB) binding to the cell membrane
13,100
 is shown in 
Figure 5.  (1) CTB moves from the solution phase to the membrane surface, followed by one of 
its binding sites attaching to a glycolipid receptor; (2) Free glycolipids diffuse two 
dimensionally, encounter the bound CTB, and then enable subsequent binding. The synergistic 
effort amongst various binding pockets, membrane receptors, and membrane dynamics 
dramatically influences the overall association.
101
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Figure 5: A schematic of the proposed CTB binding mechanism. CTB first diffuses from 
the solution phase to a membrane surface. One of its binding subunits finds a strongly 
binding receptor and then forms a relatively stable membrane bound state. Free glycolipid 
receptors diffuse two dimensionally, encounter the bound CTB, and then enable subsequent 
binding. The reaction rate on the two-dimensional membrane surface is significantly higher 
than the rate in three-dimensional bulk solutions. Thus, a weakly binding receptor, such as 
GM2, can participate in subsequent binding, leading to an enhanced binding capacity. 
Reprinted with permission from Krishnan et al.
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We recently developed a unique nanocube sensor by integrating supported lipid bilayer 
and plasmonic sensing technologies.
51
 This new tool has enabled label-free detection of protein 
binding to model membrane surfaces using a standard laboratory spectrophotometer to observe 
the extinction spectrum shift of the quadrupolar localized surface plasmon resonance (LSPR) 
peak.
75
 The nanocube sensor was used to investigate the multivalent binding principle of CTB 
interacting with various glycolipids.
75
 We observed that the amount of CTB binding onto the 
surface containing fucosyl-GM1 was higher than GM1 although the dissociation constant of 
GM1 was an order of magnitude lower than that of fucosyl-GM1. This unintuitive result might 
be attributed to a reduced binding cooperativity between fucosyl-GM1 receptors leading to an 
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increased binding capacity.
75
 Our previous findings indicated that dissociation constants cannot 
exclusively represent multivalent CTB bindings and that binding cooperativity also plays an 
essential role in determining CTB-cell membrane recognition.  
Multivalent binding can be either homo-multivalent (i.e. a protein binds to multiple 
copies of the same type of receptor) or hetero-multivalent (i.e. a protein simultaneously binds to 
two or more different types of receptors).
102
 Due to the complexity of hetero-multivalency, most 
studies have focused on homo-multivalency. However, homo-multivalent models neglect the 
inherent heterogeneity of cell membranes. We recently reported that adding a weak glycolipid 
receptor (GM2) to a model membrane containing fucosyl-GM1 significantly increased the total 
amount of bound CTB.
75
 This was unexpected, as GM2 receptors have negligible binding avidity 
in bilayers with GM2 as the only glycolipid receptor. A few other studies have also reported that 
lectin binding to glycan mixtures is stronger than the binding to a single glycan.
34-37
 However, 
the mechanism of such hetero-multivalency is not clear.  
The goal of this study was to gain insight into the mechanism of hetero-multivalent CTB 
binding. We first investigated the binding cooperativity of CTB to various glycolipid mixtures. 
Positive cooperativity was observed when GM2 was mixed with any of the other three strongly 
binding receptors (GM1, fucosyl-GM1, and GD1b). We hypothesized that the increase of CTB 
binding is caused by a reaction rate enhancement mechanism, “reduction of dimensionality”. 
(Figure 5) Once CTB has attached to a strong receptor, subsequent binding events are confined 
on the two-dimensional membrane surface. Therefore, even a weak GM2 receptor could now 
participate in second or higher order binding events because its surface reaction rate is around 
10
4
 times higher than the rate in the bulk solution. To test this hypothesis, we modulated the 
fluidity and heterogeneity of the model membrane by adding cholesterol or altering the fatty acid 
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composition of phospholipids and observed significant changes in the heterogeneous binding 
cooperativity. This complies with the surface reaction’s strong dependence on the membrane 
environment. Our results indicated that the traditional protein binding assay, which detects 
protein interactions with a specific receptor one by one (e.g. microarray technology), is not 
appropriate to explore multivalent binding interactions. To discover all possible receptors that 
could participate in a binding process, we designed a new membrane perturbation protocol that 
can efficiently screen possible glycolipid receptors involved in multivalent protein binding. 
Materials & Methods 
Materials 
Monosialoganglioside GM1 (NH4
+
salt) (Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc-
Ceramide, GM1), monosialoganglioside GM2 (NH4
+
salt) (GalNAcβ1-4(Neu5Acα2-3)Galβ1-
4Glc-Ceramide, GM2), monosialoganglioside GM3 (NH4
+
salt) (Neu5Acα2-3Galβ1-4Glc-
Ceramide,GM3), fucosylated monosialoganglioside GM1 (NH4
+
salt) (Fucα1-2Galβ1-
3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc-Ceramide, fucosyl-GM1) and disialoganglioside GD1b 
(NH4
+
salt) (Galβ1-3GalNAcβ1-4(Neu5Acα2-8)(Neu5Acα2-3)Galβ1-4Glc-Ceramide,GD1b) 
were purchased from Matreya LLC (State College, PA). 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine - sodium salt (DOPS), 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-dimyristoyl-sn-glycero-3-
phospho-L-serine – sodium salt (DMPS) were obtained from Avanti Polar Lipids (Alabaster, 
AL). Cholera Toxin subunit B (CTB, lyophilized powder) from Vibrio cholerae, cholesterol and 
casein from bovine milk were purchased from Sigma-Aldrich. GM1 oligosaccharide (GM1os) 
(Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glc) sugar was purchased from Elicityl (Crolles, 
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France). All the CTB binding experiments were performed in Tris-buffered saline-TBS (Sigma 
Aldrich). 
Methods 
Synthesis and calibration of the nanocube sensor 
Silica coated silver nanocubes were prepared as reported in our previous publication.
75
 
The silver nanocube synthesis was based on the polyol method. The synthesis of the silica shell 
on the nanocubes was performed in a scaled-up synthesis batch using 2-propanol as the solvent. 
The quality of the nanocube sensor, including silica shell thickness, nanocube size and 
uniformity, was confirmed by transmission electron microscopy (FEI Technai G2 F20 FE-TEM). 
(Figure 27) The refractive index sensitivity of silica coated silver nanocubes was reported as 
peak shift (reported in nm) per refractive index unit (RIU). (Figure 28) Since the change in 
refractive index is directly proportional to the amount of bound proteins, LSPR peak shift allows 
an estimation of the amount of protein bound.
51
  
Supported lipid bilayer preparation 
Lipids stored in organic solvents (chloroform for DOPC, DOPS, DMPC, and DMPS or a 
chloroform/methanol/water mixture for glycolipids) were mixed to obtain the desired final 
composition. They were then dried using a rotary evaporator (Heidolph Hei-VAP Value
®
), 
followed by rehydration with Milli-Q
®
 water. Small unilamellar vesicles (SUVs) were prepared 
by the standard extrusion protocol described in our prior publication.
75
 A previously established 
modified vesicle fusion technique
75
 was used to form supported lipid bilayers. The lipid bilayer 
coated nanocubes were incubated with 0.5 mg/ml casein in 1X TBS solution for 1 hour to 
prevent nonspecific binding of CTB. 
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CTB binding measurement 
The lipid bilayer coated nanocubes were incubated with the required CTB concentration 
for 1.5 hours. Blank solutions were also prepared for each CTB concentration by mixing buffer 
and CTB corresponding to that composition. The extinction spectra of the solutions were 
measured in a 384 well plate with a UV/Vis microplate spectrophotometer equipped with a CCD 
(FLUOstar Omega
®
, BMG-Labtech). All measurements were carried out at room temperature, 
except the membrane fluidity experiment involving DMPC. The location of the quadrupolar 
LSPR peak was calculated by fitting the measured absorption spectra to a seventh order 
polynomial. Each protein binding measurement was repeated in eleven wells. Each data point is 
represented as the mean ± standard deviation (S.D.) where n = 11. The experimental conditions 
for each binding measurement are described below. 
Combinatorial glycolipid array  
To acquire binding curves for the pure glycolipid systems (1 mol% glycolipid along with 
89 mol% DOPC and 10 mol% DOPS), the CTB concentration was varied from 0 to 1726 nM. 
For the binary mixture of glycolipids (1 mol% of each glycolipid along with 88 mol% DOPC and 
10 mol% DOPS), the CTB concentrations used were 706 nM and 1726 nM.  
GM1os pre-bound CTB binding experiment 
345 nM CTB was incubated at various sugar (GM1os) concentrations (0 ~ 38.1 µM) prior 
to the binding measurement. The resulting GM1os-CTB complex was incubated with the bilayer 
containing 2 mol% glycolipid along with 88 mol% DOPC and 10 mol% DOPS. 
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Membrane perturbation protocol 
The reference bilayer comprised of 0.25 mol% of each glycolipid (GM1, GM2, GM3, 
fucosyl-GM1 and GD1b), 10 mol% DOPS and 88.75 mol% of DOPC. For the perturbed 
membranes, one of the glycolipids was increased to 2 mol% while other glycolipids were 
maintained at 0.25 mol% along with 10 mol% DOPS and 87 mol% DOPC. Each experiment was 
treated with 0.5 mg/ml Casein in 1X TBS buffer to block non-specific binding and then 
incubated with 1726 nM CTB for 2 hours.  
Results 
CTB Binding to Glycolipid Pairs 
Our previous study demonstrated that mixing GM2, a weak binding receptor, with 
fucosyl-GM1 could enhance the overall CTB binding.
75
 In order to understand the mechanism of 
this hetero-multivalency, we constructed a combinatorial array of glycolipids to evaluate the 
cooperativity of CTB binding. The array was composed of glycolipids like GM1, GM2, GM3, 
fucosyl-GM1, and GD1b. (Figure 6) We first examined CTB binding to model membranes 
containing 1 mol% of a glycolipid. (Figure 6b) The shift in the location of the LSPR peak with 
respect to the control is directly proportional to the amount of CTB bound. CTB exhibited 
significant binding to the bilayers containing GM1, fucosyl-GM1, or GD1b. (Figure 6b) GM2 
and GM3 showed negligible binding with CTB even at the highest CTB concentrations (1726 
nM); this result was consistent with prior studies.
84,103,104
 Thus, we categorized GM1/fucosyl-
GM1/GD1b as strongly binding receptors and GM2/GM3 as weakly binding receptors.  
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Figure 6: Homo-multivalent CTB binding. (a) Structures of glycolipids used in the study. 
(b) Equilibrium binding of CTB to pure glycolipids. The glycolipid composition in each case 
was 1 mol%. Data points are reported as mean ± S.D (n = 11). Reprinted with permission 
from Krishnan et al.
18
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The combinatorial array was prepared by mixing two glycolipids in a 1:1 ratio (1 mol% 
of each glycolipid). The amount of CTB bound to the glycolipid mixtures was measured at two 
different CTB concentrations (706 nM and 1726 nM). From the CTB-glycolipid binding curves 
(Figure 6b), we can see that CTB binding to the model membrane is approximately saturated at 
1726 nM. Thus, we used this value to estimate the maximum binding capacity of the model 
membrane. We also measured the CTB binding at a lower CTB concentration (706 nM) to 
observe the influence of CTB concentration on binding cooperativity.  
To quantify the binding cooperativity of hetero-multivalency, we have defined 
heterogeneous binding cooperativity (θ) as:  
Equation 2 
θ = 
 LSPR shift when CTB binds to a bilayer containing paired glycolipids 
Sum of LSPR shift when CTB binds to a bilayer containing each individual glycolipid 
 
If there is no cooperativity between two glycolipids, θ should equal 1. When θ is larger or 
smaller than 1, it represents positive or negative cooperativity, respectively. The calculated 
heterogeneous cooperativity was reported in Table 2. We observed positive cooperativity when 
GM2 was mixed with any of the strongly binding receptors (GM1, fucosyl-GM1, and GD1b) at 
both CTB concentrations. Since negligible CTB binding was observed with the model membrane 
surface containing GM2 as the only glycolipid receptor, the strongly binding receptors seemed to 
have activated GM2 receptors, which led to a higher CTB binding. However, no significant 
cooperativity was observed when GM3 was mixed with strongly binding receptors. In addition, 
cooperative action between strong receptors was negligible. 
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Table 2: Calculated heterogeneous binding cooperativity between two glycolipids. Column 
and row headings represent the mixture of two glycolipids. Each cell contains two values that 
represent the calculated cooperativity at the two CTB concentrations, 706 nM (top)/1726 nM 
(bottom). Cooperativity values are reported as mean ± S.D (n = 11). The raw data of CTB 
binding was reported in Figure 29 and Figure 30. Reprinted with permission from Krishnan et 
al.
18
 
GM1 fucosyl-GM1 GD1b GM2 GM3   
  1.08 + 0.03 0.92 + 0.02 1.46 + 0.17 1.16 + 0.26 
GM1 
1.12 + 0.03 1.05 + 0.04 1.99 + 0.28 0.92 + 0.20 
   0.94 +  0.02 1.57 + 0.07 1.19 + 0.06 
fucosyl-GM1 
 1.10 + 0.03 1.54 + 0.09 1.11 + 0.04 
    2.06 + 0.08 1.05 + 0.05 
GD1b 
  1.96 + 0.10 0.98 + 0.05 
     1.00 + 0.77 
GM2 
   1.00 + 0.12 
      
GM3 
    
 
 
Possible Causes of Heterogeneous Cooperativity 
To the best of our knowledge, positive cooperativity between GM2 and other glycolipid 
receptors has not yet been reported. Several possible reasons may cause this heterogeneous 
cooperativity, including induced glycolipid cluster formation, allosteric regulation, and reduction 
of dimensionality. Each hypothesis is considered and discussed in the following paragraphs.  
Cremer and his coworkers have demonstrated that increasing GM1 density in a model 
membrane induces the formation of GM1 clusters, leading to weaker CTB binding.
105
 If mixing 
GM2 had induced the disturbance of glycolipid clusters leading to increased CTB binding, the 
addition of other glycolipids should have altered the clustering of glycolipid receptors as well 
and caused some change in binding cooperativity. However, we observed cooperative 
interactions only between GM2 and other strongly binding glycolipids. Furthermore, the 
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glycolipid concentration was kept relatively low (less than 2 mol%) to minimize any 
heterogeneous distribution of glycolipids on the membrane surface. Therefore, we believe that it 
is less likely for induced heterogeneity to be the major cause of positive cooperativity.  
Allosteric regulation is another possible cause of positive cooperativity. The bound 
glycolipids (GM1/fucosyl-GM1/GD1b) could have enhanced the binding energy between GM2 
and its adjacent binding sites, enabling GM2 to participate in the CTB binding process and 
leading to a higher binding capacity. (Figure 7a) To test this hypothesis, we modified the 
saturation binding assay developed by Leach et al. for detection of allosteric interactions.
106
 
Klassen and his coworkers have reported that at the equilibrium state CTB forms a binding 
complex with GM1 oligosaccharide (GM1os), an allosteric modulator that contains the same 
glycan structure as the GM1 glycolipid without its ceramide tail.
107
 We first incubated CTB with 
various concentrations of GM1os oligosaccharide. Then, we measured the binding of the 
GM1os-CTB complex to a model membrane containing 2 mol% glycolipid (GM2 or fucosyl-
GM1) at a fixed CTB concentration (345 nM). (Figure 7b) If the bound GM1os had altered the 
energetics of the adjacent CTB binding subunit, the allosteric effect should have initiated the 
attachment of the GM1os-CTB complex to the membrane containing GM2. Instead, negligible 
CTB binding to the lipid bilayer having GM2 was still observed. For the lipid bilayer containing 
2 mol% of fucosyl-GM1, the amount of bound GM1os-CTB complex decreased with increased 
GM1os concentration. (Figure 7b) This is due to competitive binding between GM1os and 
fucosyl-GM1 receptors. In addition, three different research groups independently evaluated the 
allosteric effect of GM1os-CTB binding and found that the affinity constants increased by only 
twofold when the neighboring binding sites were occupied.
104,107,108
 Turnbull et al. have 
estimated the dissociation constant for CTB binding with GM2 to be 2 mM.
104
 Thus, even a 
 48 
 
twofold enhancement of the affinity constant (leading to an ~1mM dissociation constant) is not 
sufficient to promote CTB binding to GM2 at physiological concentrations. Although we cannot 
completely exclude allosteric regulation between GM2 and other strong receptors, it is probably 
not the major cause for the observed positive cooperativity.  
 
 
Figure 7: Evaluation of allosteric effect. (a) A schematic of the allosteric regulation 
hypothesis. CTB was incubated with GM1os to form a GM1os-CTB complex. Then, this 
GM1os-CTB complex was bound to a model membrane containing GM2. If GM1os 
modulated the energetics of the adjacent CTB binding pocket, the attachment of the GM1os-
CTB complex to the membrane containing GM2 should be detectable. (b) Binding of the 
CTB-GM1os complex to membrane surfaces containing 2 mol% fucosyl-GM1 and 2 mol% 
GM2. Binding of the CTB-GM1os complex to the GM2 surface was still negligible; thus, 
allosteric regulation may not be a major cause of the enhanced CTB binding. Reprinted with 
permission from Krishnan et al.
18
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Another possible cause for positive heterogeneous cooperativity is the influence of 
reduced dimensionality. Searching for reaction partners is much more efficient on a two-
dimensional membrane surface than in three-dimensional space. In 1968, Adam and Delbrück 
first proposed that organisms can shorten the diffusion time of dilute reactants by adsorption to 
cell membrane surfaces in order to enhance the reaction rates of the biological processes.
109
 
Many researchers have validated this concept and provided a comprehensive theory to describe 
this mechanism.
110-115
 Recently, Sengers et al. also reported that reduced dimensionality can 
improve the binding efficiency of a bivalent monoclonal antibody interaction with membrane 
bound targets by about 10
4
-fold.
116
 Thus, it is possible that reduction of dimensionality enhanced 
CTB binding to GM2. 
The Influence of Reduced Dimensionality   
We hypothesized that CTB first moves from the solution phase to the membrane surface 
and attaches to one of the strongly binding receptors (GM1, fucosyl-GM1, and GD1b). Jobling et 
al. have shown that a single active binding site on the CTB pentamer is sufficient for cell binding 
and intoxication;
117
 therefore, we expected CTB could form a relatively stable membrane-bound 
state with a single strongly binding receptor. (Figure 5) Once CTB is anchored to the surface, 
the effective concentration of GM2 on the two-dimensional membrane surface dramatically 
increases for subsequent bindings. Although the weak binding between GM2 and CTB implies a 
short lifetime of the CTB-GM2 complex, the enhanced effective concentration allows GM2 to 
continuously participate in the process of bind to CTB leading to an increase in binding capacity. 
This hypothesis requires the presence of a strongly binding receptor in order to anchor CTB to 
the membrane surface. 
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In order to verify this hypothesis, we first evaluated the two-dimensional and three-
dimensional reaction rates using established theoretical models.
113-115
  The reaction rate, 𝜙, can 
be written as
114
: 
Equation 3 
𝜙 = 𝑘𝑜𝑏𝑠𝐶𝐴𝐶𝐵  
where 𝐶𝐴 and 𝐶𝐵 are the number densities of the two reactants, and 𝑘𝑜𝑏𝑠 is the empirical rate 
constant. In diffusion controlled reactions, 𝑘𝑜𝑏𝑠 is a function of diffusion coefficients (𝐷3𝐷 𝑜𝑟 2𝐷), 
the radius of diffusion spaces (𝑏), and the encounter radius of the target receptor (𝑎). Based on 
our experimental conditions, the bulk concentration of CTB (species A) and glycolipid (species 
B) were estimated as: 𝐶𝐴  =  3 ×  10
−7  𝑚𝑜𝑙 𝐿⁄ , 𝐶𝐵  =  3 ×  10
−7  𝑚𝑜𝑙 𝐿⁄ . Three-dimensional 
diffusivities of CTB and glycolipid containing liposomes were estimated using the Stokes-
Einstein equation as 𝐷𝐴,3𝐷 =  9.77 × 10
−11  𝑚2 𝑠⁄  and 𝐷𝐵,3𝐷  =  4.88 × 10
−12  𝑚2 𝑠⁄ . The 
measured diffusivity of bound CTB was acquired from literature (𝐷𝐴,2𝐷 =  2.5 ×
10−13  𝑚2 𝑠⁄ ).118,119 DOPC lipid diffusivity was 𝐷𝐵,2𝐷  =  8.25 × 10
−12  𝑚2 𝑠⁄ .120 Using 
different fluorescent labeling approaches, previous researchers have also reported the diffusivity 
of GM1 in DOPC bilayer to be around 3.6~8 × 10−12  𝑚2 𝑠⁄ . 120-122 We estimated the three-
dimensional reaction rate using Smoluchowski’s relation which gives a steady-state rate constant 
for fast reactions,
114
  
Equation 4 
𝑘𝑜𝑏𝑠,3𝐷 = 4𝜋𝑎(𝐷𝐴,3𝐷 + 𝐷𝐵,3𝐷) 
Prior studies derived the approximate solution of 𝑘𝑜𝑏𝑠 for two-dimensional membrane 
reactions using Smoluchowski theory, mean-passage time theory, and statistical thermodynamic 
theory (the models are summarized in APPENDIX B).
113-115
 Based on our experimental 
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conditions, we found that the two-dimensional reaction rate could be up to 10
4
 higher than the 
three-dimensional reaction rate. The increased reaction rate implies that the effective 
concentration of reactants on the membrane surface is enhanced by about 10
4
-fold. This 
calculated enhancement factor has the same order of magnitude as the value in the antibody 
system reported by Sengers et al.
116
 In such a case, the reduction of dimensionality could raise 
the effective GM2 concentration close to or higher than the dissociation constant of CTB-GM2 
(2mM). Thus, it is possible that this significant enhancement of reaction rate between bound 
CTB and GM2 led to higher CTB binding.  
To further verify this hypothesis, we altered the diffusivity of glycolipids by replacing 
DOPC with DMPC that has a gel phase transition temperature near room temperature (24 °C). 
We conducted the measurements of CTB binding to DMPC model membranes with 1 mol% 
GM1 and GM1:GM2 mixture (1 mol%:1 mol%) at 15 °C and 45 °C. In the DOPC bilayer, which 
has transition temperature at -20 C,123 the cooperativity between GM1 and GM2 at 15 °C was 
quite similar to what we obtained at room temperature, which implies that such a temperature 
change does not alter CTB binding much (Figure 8). However, the diffusion of glycolipids in the 
DMPC gel phase is two orders of magnitude lower when compared to the fluidic DMPC 
membrane.
124,125
 Goins et al. reported GM1 diffusivity to be approximately 1-2 x 10
-13
 m2/s in 
DMPC below 20 ℃.126 Under this condition, the two-dimensional reaction rate is only 400-500 
times higher than the three-dimensional reaction rate in the DMPC gel phase. Thus, we expected 
that the rate enhancement via reduced dimensionality would be minimized in the DMPC system 
at 15 C. Figure 8 shows that mixing GM2 with GM1 in a DMPC bilayer did not enhance the 
overall CTB binding at 15 °C; in contrast, binding enhancement was observed in the fluidic 
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DMPC bilayer at 45 °C. This result further corroborates our hypothesis that reduction in 
dimensionality is influencing the binding of CTB with heterogeneous mixtures of glycolipids. 
 
 
Figure 8: CTB binding to single glycolipid (orange) or paired glycolipids (green) in 
different membrane environments. (DMPC/DMPS (15 °C), DOPC/DOPS (15 °C), 
DMPC/DMPS (45 °C), DOPC/DOPS (room temperature) or DOPC/DOPS/cholesterol (room 
temperature)) The heterogeneous binding cooperativity between GM1 and GM2 depends on 
the fluidity and heterogeneity of the membranes. Data points are reported as mean ± S.D (n = 
11). Reprinted with permission from Krishnan et al.
18
 
 
 
In addition, 10 mol% of cholesterol was added to the DOPC bilayer in order to alter the 
fluidity and the heterogeneity of model membranes. Similar to the DMPC system, changing the 
membrane environment altered the heterogeneous binding cooperativity. (Figure 8) This result is 
not surprising because many studies have shown the compositions of fatty acids and cholesterol 
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in host cells can influence toxin potency.
127,128
  Previous studies have also reported that surface 
diffusion and heterogeneity can influence the homo-multivalent CTB-GM1 binding.
129
 Our result 
indicated that the membrane environment is also essential in the hetero-multivalent binding 
process.  
The other question is why mixing GM3 with the other receptor did not enhance CTB 
binding. The only difference in the structure of GM2 and GM3 is that GM2 contains an 
additional N-acetyl galactosamine (GalNAc) in its glycan portion. The crystal structure of CTB-
GM1 complex indicates that the sugar groups of galactose (Gal), GalNAc, and sialic acid 
(Neu5Ac) in GM1 were buried in the CTB binding subunit and contribute to 39%, 17%, and 
43% of the contact surface area respectively.
130
 CTB binding to GM3 that has only one Neu5Ac 
epitope should be weaker than to the GM2 receptor. In fact, Turnbull et al. estimated the 
dissociation constant for -methyl sialoside, which contains only Neu5Ac epitope, to be 210 
mM.
104
 Even though the mechanism of reduced dimensionality could increase the reaction rate 
around 10
4
-fold, the effective concentration of GM3 on the membrane surface is still far below 
the dissociation constant between CTB and the sialic acid residual. Therefore, it was not 
surprising that no cooperativity was found between GM3 and the other binding receptors. 
A New Perturbation Protocol for Screening Glycolipid Receptors in Multivalent Interactions 
One of the difficulties in observing hetero-multivalency is that some receptors, such as 
GM2, only exhibit significant binding when they form a partnership with other receptors. 
Traditional ligand-receptor binding assays (e.g. microarray technology) cannot reflect such 
hetero-multivalency because they screen only one specific receptor at a time. Thus, the 
contribution of GM2 was often ignored since CTB binding to pure GM2 was only detected at 
CTB concentrations far beyond physiologically relevant conditions. To address this issue, 
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previous studies have developed combinatorial arrays that mix two different receptors in a 1:1 
ratio.
35
 However, this labor-intensive method cannot observe hetero-multivalent binding 
involving more than two receptors.  
In order to efficiently discover receptor candidates for multivalent binding proteins, we 
designed a new membrane perturbation protocol. This protocol first involves constructing a 
membrane that contains all receptor candidates with known compositions as a reference. The 
reference membrane is then perturbed by increasing the density of a single desired glycolipid 
receptor. If a specific receptor can either directly bind to the target protein or indirectly form a 
binding complex with the assistance of other glycolipids; the perturbation will alter the overall 
protein binding irrespective of the mechanism.   
As a proof-of-concept, we constructed a reference membrane consisting of GM1, GM2, 
GM3, fucosyl-GM1, and GD1b (0.25 mol% of each glycolipid). We then perturbed the reference 
membrane by increasing one of the glycolipid receptors to 2 mol%. CTB binding to the reference 
membrane and each perturbed membrane is shown in Figure 9. As expected, CTB binding was 
significantly enhanced when the densities of GM1, fucosyl-GM1, and GD1b were increased.  
The positive binding cooperativity between GM2 and the other glycolipids present in the 
reference membrane also enhanced the overall CTB binding. In addition, increasing GM3 
density did not enhance CTB binding. Thus, we could exclude GM3 as a CTB receptor candidate 
without conducting the entire combinatorial array measurement. In order to identify receptors of 
multivalent proteins from a large library of molecules, this perturbation method can be more 
efficient than combinatorial glycolipid arrays. 
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Figure 9: The demonstration of membrane perturbation protocol. 1726 nM CTB was 
bound to the reference and perturbed membranes that preserved all receptor candidates. The 
reference membrane contained 88.75 mol% DOPC, 10 mol% DOPS, 0.25 mol% each of 
GM1, GM2, GM3, GD1b and fucosyl-GM1. The reference membrane was perturbed by 
increasing the density of a specific glycolipid to 2 mol%. Data points are reported as mean ± 
S.D (n = 11). Reprinted with permission from Krishnan et al.
18
 
 
 
Discussion 
In this study, significant enhancement of CTB binding was observed when a strongly 
binding receptor was mixed with a weakly binding receptor (GM2). When investigated further, 
the reduction of dimensionality looks like the most likely cause. If this mechanism is valid, a 
fraction of the bound CTB should simultaneously bind to GM2 and other strong binding 
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receptors. Most recently, Klassen and his coworkers demonstrated the same heterogeneous 
binding cooperativity using a catch-and-release electrospray ionization-mass spectrometry (CaR-
ESI-MS) assay.
131,132
 Mass spectrometry allows for the identification of the types of receptors 
binding to CTB. Using CaR-ESI-MS  assay, Klassen and his coworkers observed that CTB could 
bind to very weak binding receptors GM2 and GM3 when  7 different glycolipids (GM1, GM2, 
GM3, GD1a, GD1b, GD2, and GT1b) were mixed in either picodiscs or micelle systems, but no 
binding was observed when GM2 or GM3 was the only receptor. Their results provide evidence 
that CTB can directly bind to weakly binding receptors when they are mixed with strongly 
binding receptors. It is worth noting that we did not observe binding cooperativity between GM1 
and GM3, but Klassen and his coworkers observed CTB binding to GM3. This is probably due to 
the difference of lipid bilayer conditions. In our experiment, surface density of glycolipid 
receptor was maintained at 1 mol%. The CaR-ESI-MS assay mixed 7 glycolipid receptors 
equally resulting in 14 mol% of each glycolipid. The reaction enhancement via reduced 
dimensionality was higher in the CaR-ESI-MS assay; thus, it is not surprising that Klassen and 
his coworkers observed CTB binding to GM3. 
Reduction of dimensionality provided a potential mechanism to answer a long-standing 
question, why CTB binding does not correlate with GM1 level on cell surfaces.
133
 Yanagisawa et 
al. observed strong reactivity between CTB and embryonic neuroepithelial cells in the absence of 
GM1.
24
 Kirkeby stained GM1 with CTB and anti-GM1 antibody, and found that both labeling 
reagents were not co-localized.
29
 In addition, GM1 is of very low abundance (0.0015-0.003 
mol% of glycosphingolipids) in human small intestinal epithelial cells
31
; thus, a recent 
publication raised a question, whether GM1 is sufficient to induce cholera toxin attachment.
30
  In 
the reduction of dimensionality model, high-affinity receptors can serve as initiators, and then 
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activate weak receptors, leading to higher retention of CTB on the cell surface. Thus, the overall 
CTB binding is not simply controlled by a single GM1 receptor; the weakly binding receptors 
can contribute to CTB binding via reduction of dimensionality. Surface diffusion and local 
density of membrane receptors can influence the two-dimensional reaction rate, membrane 
fluidity and heterogeneity (i.e. lipid raft) which can also play essential roles in the CTB binding 
process.    
The mechanism of reduced dimensionality has also been used to explain unexpected 
phenomena in various multivalent binding studies.
34,100,116
 For example, Mazor et al. observed 
that the binding avidity of a bispecific antibody to receptors confined in cell membrane surfaces 
were significantly higher than the binding avidity to free receptors in solution.
38
 Sengers et al. 
established a mathematical model based on the reduced dimensionality hypothesis to describe the 
mechanism of bivalent antibody binding to heterogeneous membrane targets, and estimated that 
the effective affinity of the bivalently bound antibody can be enhanced by approximately 4 
orders of magnitude.
116
 These studies, combined with our own CTB binding measurements 
suggest the importance of the role of reduced dimensionality in multivalent protein-cell 
membrane recognition. Further kinetic studies are necessary in order to verify the hypothesis and 
establish a comprehensive model of hetero-multivalent recognition. 
Since the complex interplay between multiple membrane receptors is critical, we also 
developed a new membrane perturbation protocol to efficiently screen receptor candidates. This 
protocol measured CTB binding to perturbed membranes that preserve all receptor candidates; 
therefore, the interplay between different receptors can be monitored. This new protocol is more 
efficient in screening the potential receptors than the combinatorial array, which detects proteins 
binding to the binary mixture of glycolipids. For example, if we plan to screen 20 receptor 
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candidates, the membrane perturbation protocol required only 21 measurements instead of 190 
measurements in a combinatorial array.  
Chapter Conclusion 
In summary, we elucidated the essence of hetero-multivalency in CTB-cell membrane 
recognition using a high-throughput and easy-to-use nanocube sensors. We believe that the 
detection protocols presented here can provide a systematic and efficient strategy to investigate 
multivalent protein-cell membrane recognition. 
 
59 
 
CHAPTER IV  
HETERO-MULTIVALENCY OF PSEUDOMONAS AERUGINOSA LECTIN LECA 
BINDING TO MODEL MEMBRANES 
 
Chapter Summary 
Multivalency is at the heart of lectin-glycan recognition. We demonstrated hetero-
multivalency, a protein simultaneously binding to two or more different types of receptors, may 
play an essential role in LecA (a Pseudomonas aeruginosa adhesin)-glycolipid recognition. We 
observed that low-affinity receptors could be activated by high-affinity receptors, resulting in 
higher LecA binding capacity. Activation was probably mediated via a Reduction of 
Dimensionality (RD) mechanism. In this work, we investigated the binding cooperativity of 
LecA to various glycolipid receptors and mixtures of those same receptors. Interestingly, the 
strongly binding receptor, Gb3, could activate weaker binding receptors (i.e. LacCer, GalβCer, 
Gb4, AGM2, GM1, and AGM1) leading to higher LecA binding capacity. In addition, medium-
affinity receptors, GM1 and AGM1, could also initiate LecA binding to each other and to weak 
receptors. Moreover, we identified specific requirements for hetero-multivalent binding. LecA 
concentration and the surface density of weak receptors must reach specific thresholds to trigger 
binding cooperativity.  
Introduction 
Pseudomonas aeruginosa is a ubiquitous and opportunistic bacterium. The increase of 
antibiotic resistance worldwide limits therapeutic options, leading to the high morbidity and 
mortality of P. aeruginosa infections.
134,135
 One mechanism that P. aeruginosa uses to cause 
disease is adhesion to epithelial cells.
9-12
 Adhesion of P. aeruginosa is mediated by surface 
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adhesins, including LecA (i.e. PA-IL), LecB (i.e. PA-IIL), and Type IV pilus (T4P), which bind 
to glycan receptors on epithelial cell surfaces.
136-140
 In addition to their role in adhesion, LecA 
and LecB can influence host cell functions.
140-145
 Thus, it is essential for us to understand the 
binding mechanisms used by P. aeruginosa adhesins to interact with host cell receptors in order 
to gain insight into strategies to combat infections. 
In this article, we focus on LecA, a homotetrameric lectin, where each monomer has a 
single glycan binding site.
41
 LecA contains two adjacent binding site pairs facing in opposite 
directions. (Figure 10) This configuration allows adhesion of P. aeruginosa to epithelial cells 
and may contribute to linkages between bacteria, subsequently leading to biofilm 
formation.
138,146
 It is known that LecA prefers binding to α-D-galactose terminated glycans; 
typically, globotriaosylceramide (i.e. Gb3, Galα1-4 Galβ1-4 Glc ceramide) is considered to be a 
major receptor for LecA.
41,147-151
 However, it is known that LecA can bind to other types of 
glycan receptors (e.g. β-galactose (Galβ) and N-acetylgalactosamine (GalNAc) terminated 
glycans), but the binding affinities are lower than that of binding to Gb3. 
150,152
  
We recently reported a hetero-multivalent binding phenomenon for cholera toxin subunit 
B (CTB) in an environment that mimics the natural cell membrane.
17,18
 Interestingly, we found 
that strong binding receptors can activate weak binding receptors via a fundamental mechanism, 
Reduction of Dimensionality (RD).
18
 We illustrate the concept of RD in Figure 10, which shows 
the stepwise process of LecA binding to a cell membrane containing two different glycolipid 
receptors. The binding mechanism includes: (1) a molecule diffuses from solution phase to a 
membrane surface and one of its binding sites attaches to a membrane receptor; (2) Free 
membrane receptors move two dimensionally, encounter the now bound molecule, and enable 
subsequent binding events. The reaction rates of these subsequent binding events are at least 10
4
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times higher than the first binding event.
18
 Thus, even a weak binding receptor can now 
participate in the second or higher order binding events resulting in greater protein attachment. 
This intrinsic mechanism suggests that the binding of multivalent proteins is not simply 
controlled by a single type of receptor; the cooperative actions between strong and weak 
receptors can greatly influence the overall attachment of proteins and bacteria. 
 
 
Figure 10: Schematic for the Reduction of Dimensionality (RD) model. (a) A schematic 
representation of RD influencing LecA interactions with the cellular membrane. LecA first 
diffuses from solution to a membrane surface and attaches to the high-affinity receptor, Gb3. 
Then, free membrane receptors move two dimensionally, enabling subsequent binding. The 
reduced dimensionality of diffusion enhances the effective concentrations of membrane 
receptors; thus, a weak receptor, such as LacCer, can contribute to LecA binding. (b) 
Graphical representation of LecA complexed with galactose as observed in the crystal 
structure (PDB  code 1OKO).
147
 The four binding sites are indicated by arrows. The protein 
and carbohydrate structures are displayed in a cartoon representation with coloring done by 
subunit using JSmol. 
 
 
We hypothesized that the RD mechanism plays a key role in P. aeruginosa adhesion by 
influencing many different multivalent proteins, including LecA. Although Gb3 is the major 
LecA receptor, its surface concentration in different epithelial cells is not known. Gb3 is at low 
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levels in human intestinal epithelia cells and murine lungs.
31,153
 We suspect that Gb3 can activate 
abundant but weaker glycolipid receptors, influencing LecA attachment via the RD mechanism. 
We examined hetero-multivalency in LecA binding through analysis of hetero-multivalent 
binding cooperativities between major and minor LecA binding receptors. We were excited to 
find that high-affinity receptors were able to activate weak binding receptors, leading to positive 
hetero-multivalent cooperativity. We performed colloid aggregation assays to evaluate the 
energetics involved in hetero-multivalent binding. We found that the RD mechanism leads to 
enhancement of LecA and P. aeruginosa adhesion through multivalent receptor interactions. 
Methods & Materials 
Materials 
Ammonium hydroxide, bovine serum albumin Fraction V (BSA), copper (II) chloride 
dihydrate, ethanol, Pluronic F-127, polyvinylpyrrolidone (MW ~55,000) (PVP), tetraethyl 
orthosilicate (TEOS), silicone oil (useable range -50°C to +200°C) and tris-buffered saline (TBS) 
obtained as a 10x solution (1x working solution 20 mM Tris 0.9% NaCl pH ~7.4) were 
purchased from Sigma-Aldrich (St. Louis, Missouri). Silver(I) nitrate Premion grade was 
purchased from Alfa-Aesar (Tewksbury, Massachusetts). 2-Propanol (iPA) and Texas Red™ 
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (TR-DHPE) was 
purchased from Fisher Scientific (Pittsburgh, Pennsylvania). 1,5-Pentanediol (PD) was 
purchased from Acros Organics (Geel, Belgium). PA-IL from Pseudomonas aeruginosa (also 
known as LecA) was purchased from Elicityl (Crolles, France). 5.04 µm silica beads were 
purchased from Bangs Laboratories Inc. (Fishers, Indiana). Calcium chloride was from BDH 
VWR Analytical (Radnor, Pennsylvania). Monosialoganglioside, GM1 (Galβ1-3GalNAcβ1-
4(Neu5Acα2–3)Galβ1-4Glc-Ceramide), Gangliotetraosylceramide, AGM1,(Galβ1-3GalNAcβ1-
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4Galβ1-4Glc-Ceramide),  Gangliotriosylceramide, AGM2, (GalNAcβ1-4Galβ1-4Glc-Ceramide), 
Globotriaosylceramide, Gb3, (Galα1-4Galß1-4Glc-Ceramide), Globotetrahexosylceramide, Gb4, 
(GalNAcß1-3Galα1-4Galß1-4Glc-Ceramide), Lactosylceramide, LacCer, (Galβ1-4Glc-
Ceramide) and Galactosylceramide, GalβCer, (Galß-Ceramide)  were purchased from Matreya 
LLC (State College, PA). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (POPS) were purchased from 
Avanti Polar Lipids (Alabaster, AL). 
Methods 
Nanocube synthesis 
The nanocube synthesis procedure is originally from Tao et al. 
76
 The silver nanocubes 
were synthesized via the polyol method which uses PVP as a structure-directing agent. In brief, 
the procedure was as follows. First, 0.2 g of AgNO3 was dissolved into 10 mL of PD along with 
30 µL of 8.2 g/L CuCl2 in PD. Next, 20 mL of PD was added to a 100 mL round bottom flask 
that was then heated to 130°C with stirring in a 190°C silicon oil bath. After reaching 130 °C in 
the flask, 250 µL of the AgNO3 solution along with 500 µL of a 20 g/L PVP in PD solution was 
added to the flask followed by a second addition of 500 µL from both the AgNO3 and PVP 
solutions 35 seconds later. Then every following minute, 500 µL of each solution was added to 
the reactor until the solution turned a deep red color, about 15 minutes. After achieving a deep 
red color, the reaction was then allowed to cool and was washed by centrifugation using 200 
proof ethanol.  
The  silica coating procedure was originally described in Wu et al.
74
 and modified by 
Worstell et al.
17
 First, 20 mL of the silver nanocube solution was washed into iPA via 
centrifugation and then added to a 250 mL round bottom flask along with 55 mL of iPA, 22.1 
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mL of MilliQ® water, 6.8 mL of TEOS, and 3.4 mL of 0.84 w/v% ammonium hydroxide. Next, 
the mixture was stirred at room temperature for 60 minutes before 50 mL of ethanol was added 
to stop the reaction. After stopping the reaction, the silica coated cubes were centrifuged and 
reconstituted in 75 mL of iPA. The solution was then returned to the round bottom flask along 
with 22.1 mL of MilliQ® water, and 6.8 mL of TEOS. This solution was incubated at 60 °C for 
10 hours before being washed with MilliQ® water.  The silica coated nanocubes were stored in 
MilliQ® water at room temperature until use. 
Vesicle preparation 
Small unilamellar vesicles (SUVs) were prepared via extrusion.
17
 The procedure in brief 
is as follows. First, the desired compositions of lipids in chloroform solutions, prepared as per 
manufacturers recommendations, were mixed in a 25 mL round bottom flask and, then, dried 
using a rotary evaporator (Heidolph Hei-VAP Value
®
). Next, the dried lipids were reconstituted 
using MilliQ® water and extruded through a 100 nm polycarbonate filter (Whatman
®
) using a 
mini-extruder (Avanti Polar Lipids) resulting in a 3 g/L SUV solution. 
Supported lipid bilayer formation on Ag@SiO2 nanocubes 
Supported lipid bilayers were formed on the nanocubes using a modified vesicle fusion 
method.
17
 100 µL of the 3 g/L SUV solution was added to a 0.5 mL Eppendorf
®
 tube and vortex 
mixed for 20 seconds. Then, 10 µL of a concentrated nanocube solution was added to the tube 
and the tube was vortex mixed for 1 second. Following this, 110 µL of 2x TBS was added to the 
tube and vortex mixed for one second. These last two steps were repeated pipetting 10 μL of 
concentrated nanocube solution and 10 μL of 2x TBS each time until 100 µL of the nanocube 
solution were consumed. Then, the tube was vortex mixed for an additional 10 seconds and 
diluted with 1x TBS with 100 µM CaCl2 to the desired nanocube concentration. 
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Supported lipid bilayer formation on silica beads  
Supported lipid bilayers were formed on the silica beads using a vesicle fusion method.
154
 
Initially, the stock silica bead solution was sonicated for 10 minutes and 5 µL of the solution was 
pipetted into a 0.5 mL Eppendorf
®
 tube. The beads were then washed three times with MilliQ
® 
water and the beads were resuspended in a final volume of 25 µL. In a separate 0.5 mL 
Eppendorf
® 
tube, 25 µL of the SUV solution was added to 50 µL of 1x TBS and vortex mixed. 
Then, 25 µL of the washed beads were added to the SUV buffer solution and vortex mixed for 10 
seconds and incubated for 10 minutes. Then, the beads were blocked with BSA for 1 hour 
followed by washing with 1x TBS resulting in a final volume of 100 µL of bilayer coated beads. 
Nanocube protein binding measurement 
Bilayer coated nanocubes were incubated for 1 hour with 31.3 µL of 0.5 g/L BSA per 
1250 µL of nanocube solution to reduce nonspecific binding. Then, the desired amount of LecA 
was added.  For these experiments, 10 mol% POPS/90 mol% POPC lipid bilayer was used as a 
control. After addition of LecA, the test, control, and blank solutions were vortex mixed for 10 
seconds and pipetted as 20 µL aliquots into wells of a 384 well plate, 8 wells for the test, 4 wells 
for the control, and 4 wells for the blank solutions for each LecA concentration tested. Finally, 
the plate was read using a UV/Vis microplate reader spectrophotometer equipped with a CCD 
(FLUOstar Omega®, BMG-Labtech) to collect the extinction spectra every 13.3 minutes for a 
total of 80 minutes at room temperature. The resulting spectra were the results of averaging 200 
flashes per well at a 1 nm resolution. The location of the quadrupole LSPR (Localized Surface 
Plasmon Resonance) peak (LSPR peak) was determined by 5
th
 order polynomial fitting. The 
resulting LSPR peak shift was calculated from the average LSPR peak location of the 8 wells 
and then subtracted by the LSPR shift of the control lipid bilayer.  
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Video microscopy for silica particle aggregation  
Wells of a 96 well-plate (Costar® 3370) were coated with polyethylene glycol (PEG) 
using Pluronic F-127. Initially, each well was rinsed four times by ethanol and 250 µL ethanol 
was left to incubate in the wells for 30 minutes. Then, the wells were rinsed extensively with 
ethanol followed by five successive rinses of MilliQ
®
 water. Following the cleaning steps, 250 
µL of 5 g/L F-127 was added to each of the wells and left overnight. The next day, each well was 
rinsed five times with 250 µL of 1x TBS with 100 µM CaCl2 while ensuring that none of the 
wells dried out when removing the solution. After the final rinse, the volume of solution left in 
each PEG-coated well was 96 µL of 1x TBS with 100 µM CaCl2. 
The procedure for video microscopy was adapted from Duncan et al.
155
 5 µL of 0.0324 
g/L LecA solution in 1x TBS with 100µM CaCl2 was added to a PEG-coated well and allowed to 
mix for at least 5 minutes. After LecA addition, 4 µL of the bilayer coated silica beads were 
added to the well and images were collected for 1.5 hours at an average frame rate of 12.8 
frames/min. Imaging was performed using an inverted optical microscope (Axiovert® 200M , 
Carl Zeiss, Germany) with a 20x objective (Plan-NeoFluar, NA is 0.5, Carl Zeiss). Images were 
collected with a 14 bit CCD Camera (AxioCam HRc®, Carl Zeiss) operated in binning mode 1 
(pixel size is 308nm/pixel, image area  is 1388 X  1040 pixels
2
 = 427 X 320 µm
2
) .  An image 
analysis algorithm coded in MatLab 2016a
®
 was used to locate and track the centers of each 
particle.
156,157
  Particles were considered associated when the distance between particles centers 
was less than or equal to ≈2a+2 pixels (a is the particle radius). 
Statistical analysis and regression 
The data comprising each binding curve is given as a mean ± standard deviation (S.D.) 
where n = 8. The Hill-Waud model was then fit to the data for each binding curve via the 
 67 
 
Levenberg Marquardt algorithm in OriginPro 9.1
®
 (OriginLab). This returned the calculated 
value, standard error, and R
2
 value as well as the residuals, studentized residuals, and studentized 
deleted residuals. The parameter values and standard errors were reported in Table 5.  
Colloid Aggregation Kinetic Theory  
Duncan and Bevan measured Concanavalin A (ConA) binding to dextran by analyzing 
the aggregation kinetics of dextran-coated silica particles.
155
 Here, we adapted the same analysis 
to monitor interactions between LecA and glycolipids. Compared to the nanocube protein 
binding measurement, this aggregation kinetic analysis allowed us to directly observe the 
energetic differences of LecA binding to different glycolipid mixtures. The analysis was 
conducted by measuring the rate of single particle disappearance using video microscopy.
155
  The 
aggregation rate at short time scales was defined as: 
Equation 5 
𝜃1
−1 =
𝜙1,0
𝜙1
= 1 + 4𝑘11𝜙1,0𝑡 
where t is time in seconds and 𝜃1 is the fraction of single particles remaining over time.  𝜃1
−1 was 
determined by taking the ratio of  the number density of single particles at a certain time (𝜙1) and 
at time = 0 (𝜙1,0). 𝑘11 is the rate constant for the self-aggregation of single particles. We 
obtained 𝑘11 by fitting 𝜃1
−1 vs. time data to Equation 5. This aggregation kinetic model is valid 
for short time scales; thus, we fit the experimental data between t = 0 and t = τ. 155 The definition 
of diffusion time (τ) is described in APPENDIX C. 𝑘11 is only a function of pair potential 
between two particles, 𝑢𝑝𝑝. As 𝑘11 ≫ 0, it indicates strong binding between LecA and 
glycolipids. For weak interactions, 𝑘11 → 0. By comparing  𝑘11 values, we can observe the 
energetic differences of LecA binding to different glycolipid mixtures.  
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Results 
According to the RD model, we hypothesize that high-affinity receptors can activate 
weak binding receptors, leading to increased overall binding capacities. We focused the current 
study on LecA from P. aeruginosa. We expected the primary LecA receptor, Gb3, could 
effectively facilitate other lower affinity receptors’ ability to bind LecA, leading to greater LecA 
attachment to the lipid bilayer. Here, we used the nanocube sensing platform to observe LecA 
binding to lipid bilayers.
17,18
 The quadrupole LSPR shift in the absorption spectra represents 
LecA binding. The data point at each protein concentration represents an average over 8 
replicates. The saturation binding curves were fit by the Hill-Waud binding model
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Equation 6 
Δ𝜆𝐿𝑆𝑃𝑅 =
𝑉𝑚[𝐿𝑒𝑐𝐴]
𝑛
𝐾ℎ
𝑛 + [𝐿𝑒𝑐𝐴]𝑛
 
where Kh is the Hill’s equation apparent dissociation constant, n is the Hill cooperativity 
coefficient, [LecA] is the concentration of LecA, and Vm is the maximum ΔλLSPR
 
of the fully 
bound state. ΔλLSPR is the observed LSPR peak shift, which corresponds to the attachment of 
LecA to the lipid bilayer surface. To quantify the cooperative binding effect, we modified the 
heterogeneous cooperativity defined in our recent paper
18
:   
Equation 7 
heterogeneous cooperativity (𝜙) = Δλ𝑚𝑖𝑥 −∑ Δλ𝑝𝑢𝑟𝑒,𝑖
𝑖
 
where Δλ𝑚𝑖𝑥 is the LSPR shift when LecA binds to a bilayer containing two different 
glycolipids, and Δλ𝑝𝑢𝑟𝑒,𝑖 is the LSPR shift when LecA binds to a bilayer containing the 
correspondent individual glycolipid, i. If no enhancement is observed between two different 
glycolipids, the 𝜙 value should be approximately zero. A positive (or negative) 𝜙 value indicates 
positive (or negative) cooperativity. 
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Potential Glycolipid Receptors 
Prior glycoarray studies have shown αGal terminated glycans are LecA’s preferred 
receptors but LecA can also bind to βGal terminated glycans with lower affinity.150,152,158 Here, 
we measured LecA binding to the common galactose terminated glycolipids, including Gb3, 
GM1, AGM1, LacCer, and GalβCer. (Figure 31) As shown in Figure 11, LecA significantly 
bound to the bilayer containing 1 mol% Gb3. At the same density, LecA-AGM1 binding was 
much weaker, and LecA binding to GM1 was not measurable. When we increased the glycolipid 
density to 5 mol%, LecA binding to both AGM1 and GM1 became significant. At 5 mol% 
density, the dissociation constant (Kh) of GM1 is slightly higher than AGM1. We also noted that 
the weaker affinity GM1 had a higher Vm than AGM1. This phenomenon is similar to CTB 
binding; the homo-multivalent binding cooperativity, n, can influence the binding capacity.
17
 
LacCer and GalβCer were observed to be highly abundant in intestinal epithelium, and LacCer 
was noted as abundant in murine lungs.
31,159
 However, their binding avidities are much lower 
than GM1 and AGM1. We could not observe LecA binding to LacCer surfaces unless the 
LacCer density was increased to 8 mol%. For GalβCer, LecA binding is still not measureable at 
an 8 mol% surface density. Based on these results, we rank these glycolipids in order of affinity, 
Gb3 ≫ GM1 ≈ AGM1 ≫ LacCer > GalβCer, and categorize them into three groups: (1) Strong 
receptors: Gb3; (2) Moderate receptors: GM1 and AGM1; (3) Weak receptors: LacCer and 
GalβCer. 
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Figure 11: The saturation binding curves of LecA binding to common galactose 
terminated glycolipids. The dash lines represent the curve fits to Hill’s equation. Data 
points are reported as mean ± S.D (n = 8). To better show the data points at low 
concentrations, the same binding curves on a semi-log scale are shown in APPENDIX C. 
 
 
Positive Binding Cooperativity Between Strong and Weak Receptors (Gb3 & LacCer) 
Based on the RD model, we expected that strong receptors would activate weak 
receptors, leading to higher binding capacity for LecA. To demonstrate this concept, we 
measured LecA binding to the mixtures of Gb3 and LacCer.  Keeping the mol% of Gb3 in the 
bilayer fixed at 1 mol%, we performed measurements at telescoping concentrations of LacCer (8, 
4, 2 and 1 mol%) in the bilayer (Figure 12a). LecA binding to pure 4 mol% surface density 
LacCer was not measureable, and the maximum binding (at 3μM LecA) to pure 8 mol% LacCer 
is minimal. After mixing LacCer with 1 mol% of Gb3, we saw increased LecA binding to 
mixtures of Gb3 and LacCer. 
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Figure 12: LecA binding to Gb3/LacCer mixtures shows positive cooperativity. (a) 
Saturation binding curves of LecA binding to bilayers containing Gb3/LacCer mixtures. The 
dashed lines are the Hill equation fits to the data (represented as mean±S.D. (n=8)). To better 
show the data points at low concentrations, the binding curves on a semi-log scale are shown 
in APPENDIX C. (b) ϕ values for 1 mol% of Gb3 mixed with different densities of LacCer. 
ϕ was calculated based on the LSPR shift at the highest LecA concentration (3 µM). Dash 
line representing the fit of ϕ to the sigmoidal function is a guide to the eye. 
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As described above, we can use hetero-multivalent cooperativity (ϕ in Equation 7 to 
quantify the enhanced binding capacity. In Figure 12b, no obvious positive cooperativity was 
observed when 1 mol% Gb3 was mixed with 1 mol% LacCer, but cooperativity drastically 
increased at 2 mol% of LacCer. This result seems to be indicating that the surface density of the 
weak receptor has to reach a threshold value in order to contribute in LecA binding. 
Figure 35 shows the changes in cooperativity under different LecA concentrations. The 
average cooperativity is minimal below 0.1 μM LecA, but then increases until beginning to level 
off around 2 μM LecA. In the RD model, LecA has to first anchor to Gb3 in order to change 
from three-dimensional to two-dimensional diffusion, leading to an increased effective 
concentration of the weak receptor for the subsequent binding events. Thus, this hetero-
multivalent binding process is limited by the first binding step, which corresponds to the 
dissociation constant, Kh, of Gb3 (0.1 μM). This is probably the reason why the observed 
cooperativity significantly increased above the Kh value. 
It is important to recognize that the cooperativity defined in Equation 7 should refer to 
the change of the number of bound LecA (i.e. binding capacity) molecules. Besides the increased 
binding capacities of Gb3+LacCer mixtures, we observed that the Kh values also increased. 
(Table 5) In a simple monovalent binding model, the molar Gibbs free energy (i.e. binding 
avidity) is related to the dissociation constant
160
: 
Equation 8 
∆𝐺 = −𝑅𝑇𝑙𝑛(𝐾𝑑) 
Although this function is not applicable to multivalent binding systems, we expect that 
the increase in dissociation constant (Kh) is associated with the decrease in binding energy 
(avidity) between LecA and membrane surfaces.
81
 This phenomenon is consistent with the CTB 
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binding system. When the weak receptor GM2 was mixed with other strong receptors, the 
dissociation constants also increased.
17,18
  
Alternative Measurement of LecA Binding Avidity to Gb3 & LacCer Mixtures  
As described above, after mixing Gb3 with LacCer, we observed an increase in Kh, which 
may refer to a decrease in LecA binding avidity. As an additional confirmation of this argument, 
we used a nascent video microscopy technique developed by Duncan and Bevan to directly 
measure the binding avidity of LecA. Duncan and Bevan measured ConA and dextran 
interactions by observing the aggregation process of dextran-coated colloidal particles. ConA, an 
agglutinating lectin, has a similar configuration to LecA. The paired glycan binding sites of 
ConA facing opposite directions linked the dextran-coated silica beads, leading to colloid 
aggregation. Duncan and Bevan developed a theoretical model to describe the correlation of 
aggregation kinetics and the pair potential energy between two particles. This video microscopy 
technique not only offers us an alternative measurement of LecA binding avidity but also allows 
for direct visualization of LecA-glycolipid receptor interactions.  
To implement this technique, we first deposited lipid bilayers containing the desired 
glycolipid receptors onto 5 μm silica beads. Then, LecA was bound to glycolipid receptors 
thereby linking two silica particles. (Figure 13) The aggregation rate is associated with the 
binding energy between LecA and glycolipid receptors. Supplemental videos show the 
aggregation kinetics of lipid bilayer coated particles. If the binding avidity was strong, the 
aggregation occurred immediately after two particles touch. (Movie 1 & 2) In contrast, if the 
binding avidity is weak, we observed a fraction of particles that could collide and bounce apart. 
(Movie 3) This aggregation process can be quantified by measuring the rate of single particle 
disappearance. We calculated the aggregation rate (k11) by following the analysis developed by 
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Duncan and Bevan. (see Chapter IV Materials and Methods section). When 𝑘11 ≫ 0, it indicates 
strong binding. For weak interactions, 𝑘11 → 0. By comparing  𝑘11 values, we can observe the 
energetic differences of LecA binding to different glycolipid mixtures.  
 
 
Figure 13: Colloid aggregation kinetics. (a) A schematic drawing of silica particle 
aggregation induced by LecA-glycolipid binding. (b) A snapshot of particle aggregation 
mediated by LecA tethering. (c) A snapshot of particle dispersion without LecA. (d) Particle 
aggregation under different conditions. The decay rate of the singlet ratio (θ) is associated 
with the binding avidity between LecA and membrane receptors. 
 
 
The calculated aggregation rate (k11) at various membrane compositions is reported in the 
Table 3. The k11 value significantly decreased after adding 4 mol% LacCer to the lipid bilayer 
containing 1 mol% Gb3, indicating the binding avidity reduced in the Gb3+LacCer mixture. This 
observation is interesting. If LecA only interacts with the major receptor, Gb3, additional LacCer 
should not significantly change the binding avidity because the surface density of Gb3 remained 
at 1 mol%. This phenomenon can be explained by the RD mechanism. When LecA interacts with 
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pure 1 mol% Gb3 bilayers, a LecA could bind to maximum of four Gb3 receptors, forming a 
strong linkage between the silica beads. When LecA interacts with lipid bilayers containing a 
LacCer and Gb3 mixture, due to the increased effective concentration of LacCer, LacCer could 
compete with Gb3 receptors in LecA binding. In this situation, a portion of LecA might bind to 
both Gb3 and LacCer simultaneously, leading to a weaker linkage between two silica beads. 
 
Table 3: Aggregation rate (k11) of Gb3, LacCer, Gb3+LacCer, and control bilayers. k11 is 
represented as mean ± S.D. (n =2). N/A indicates that the S.D. was not determined. 
Lipid Compositions (mol %) Fitted 
Gb3 LacCer POPS POPC k11 
(μm2/(bead*s) 
1 0 10 89 0.20 ± 0.03 
0 4 10 86 0.03 ± N/A 
1 4 10 85 0.13 ± 0.01 
0 0 10 90 0.01 ± N/A 
 
 
This result is consistent with the dissociation constants measured by the nanocube sensor 
experiments. Based on colloid aggregation theory, the aggregation rate (k11) and the dissociation 
constants (Kh) are proportional to the logarithmic avidity
155
. Comparing pure 1 mol% Gb3 and 1 
mol% Gb3+4 mol% LacCer, the binding avidity reduced around half in both nanocube 
measurements (Kh in Table 5) and colloidal aggregation data (k11 in Table 3). This independent 
measurement of LecA binding avidity supports our hypothesis of the RD model.  
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Positive Cooperativity Between Gb3 and Other Weak Receptors (Galβ/GalNAc Terminated 
Glycolipids)  
Besides LacCer, we explored hetero-multivalent binding cooperativity between Gb3 and 
other weak glycolipid receptors. We first mixed Gb3 with the simplest glycolipid, 
galactosylceramide (GalβCer), which consists of a single β–galactose residue attached to a 
ceramide tail. GalβCer is highly abundant in the brain and intestinal epithelial cells;14,31 thus, it 
may play a role in the LecA binding process. At pure 8 mol% GalβCer, we did not observe 
significant LecA binding. This indicated that the binding affinity of GalβCer is weaker than 
LacCer. As expected, we observed possible positive cooperativity when 8 mol% GalβCer was 
mixed with 1 mol% Gb3. (Figure 14 and Table 4) However, the degree of enhancement is lower 
than the Gb3+LacCer combination. This is probably due to the weaker interaction between LecA 
and GalβCer.   
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Table 4: Binding enhancement, ϕ, calculated using Equation 7 with 3 μM LecA LSPR 
shifts. The values are the mean ± S.E. (n=8). 
Lipid compositions (mol%)  
Gb3 GM1 AGM1 LacCer GalßCer Gb4 AGM2 ϕ 
1 1 0 0 0 0 0 1.9 ± 0.3 
1 0 1 0 0 0 0 1.6 ± 0.3 
1 0 0 1 0 0 0 0.2 ± 0.2 
1 0 0 2 0 0 0 1.8 ± 0.2 
1 0 0 4 0 0 0 1.6 ± 0.2 
1 0 0 8 0 0 0 1.8 ± 0.2 
1 0 0 0 8 0 0 0.8 ± 0.2 
1 0 0 0 0 8 0 0.5 ± 0.2 
1 0 0 0 0 0 8 0.7 ± 0.2 
0 1 1 0 0 0 0 1.6 ± 0.3 
0 1 0 4 0 0 0 1.4 ± 0.2 
0 1 0 8 0 0 0 2.0 ± 0.3 
0 1 0 0 8 0 0 0.6 ± 0.2 
0 0 1 4 0 0 0 1.7 ± 0.2 
0 0 1 8 0 0 0 1.8 ± 0.2 
0 0 1 0 4 0 0 0.2 ± 0.3 
0 0 1 0 8 0 0 0.4 ± 0.2 
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Figure 14: Cooperativity between Gb3 and other weak receptors. (a) Saturation binding 
curves of LecA to the bilayers containing Gb3, GalßCer, and Gb3+GalßCer. The dashed lines 
represent Hill equation fits to the data (represented as average ± S.D. (n=8)). To better show 
the data points at low concentrations, the binding curves on a semi-log scale are shown in 
APPENDIX C (b) 1 mol% Gb3 mixed with GalNAc terminated glycolipids at 3 μM LecA. 
(average ± S.D. (n=8)). 
 
 
Prior glycoarray data showed that LecA has weak binding affinity to N-
acetylgalactosamine (GalNAc) terminated glycans.
149,150,152
 Thus, we also investigated the 
binding cooperativities of two GalNAc terminated glycolipids, Gb4, and AGM2. In this case, we 
only conducted LecA binding experiments at 3 μM, which is the highest concentration in the 
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previous binding curves. At 8 mol% of pure AGM2, no significant LecA binding was observed. 
The degree of LecA binding to 8 mol% pure Gb4 is similar to the 8 mol% pure LacCer system. 
When AGM2 was mixed with 1 mol% Gb3, we again observed potential positive cooperativity 
between strong and weak binding receptors.  This shows that Gb3 could form a partnership with 
GalNAc terminated glycolipids, leading to positive cooperativity.  
Gb3, GM1, and AGM1 Bilayers 
After seeing various levels of cooperativity for Gb3 mixed with a variety of weak 
receptors, we became interested in observing the cooperativity between Gb3 and the moderate 
receptors (AGM1 and GM1). Weak receptors were activated by increasing the effective 
concentration via the RD mechanism. Therefore, it is reasonable to assume the moderate 
receptors could be activated via the same RD mechanism. As expected, in Figure 15, we 
observed that 1 mol% Gb3 receptors could activate either 1 mol% AGM1 or GM1, leading to 
higher LecA attachment. In addition to testing cooperativity between Gb3 and moderate 
receptors, we compared the cooperativity amongst the moderate receptors themselves. In the 
mixture of 1 mol% of GM1 and 1 mol% of AGM1, we observed much greater LecA attachment 
than the values in bilayers containing 1 mol% of either GM1 or AGM1. The increase of available 
receptors in the lipid bilayer is probably the reason for the increased cooperativity among 
moderate receptors. 
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Figure 15: Cooperativity amongst Gb3, GM1, and AGM1 binary mixtures. Saturation 
curves for LecA binding to the bilayers containing mixtures of Gb3 and moderate receptors 
show positive cooperativity. The data are represented as mean ± S.D. (n=8). The dashed lines 
represent Hill equation fits to the data. To better show the data points at low concentrations, 
the binding curves on a semi-log scale are shown in APPENDIX C. 
 
 
Binding Cooperativity Amongst Moderate and Weak Receptors 
In addition to the strong receptor (Gb3), we wondered if the moderate receptors (AGM1 
and GM1) were sufficient to activate weak receptors (i.e. LacCer and GalβCer), leading to higher 
LecA attachment.  First, we investigated the binding cooperativity between LacCer and the 
moderate receptors. (Figure 16a) We observed positive cooperativity between 1 mol% of each 
moderate receptor, individually, with 4 or 8 mol% of LacCer. This observation indicated that the 
moderate receptors were able to activate LacCer, leading to the increased LecA attachment. We 
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also examined the change of cooperativity under different LecA concentrations. (Figure 35) 
Similar to Gb3+LacCer system, the cooperativity became significant when the LecA 
concentration reached a threshold value. However, the threshold concentration of the moderate 
receptors (~0.5 μM) was higher than the threshold of Gb3 (0.1μM). As discussed above, LecA 
has to first bind to high affinity receptors, leading to an increased effective concentration of the 
weak receptor for subsequent binding. The threshold LecA concentration is probably dominated 
by the first binding step, which is associated with the Kh of the higher affinity receptor. Thus, we 
observed cooperativity significantly increased after the LecA concentration reached the Kh value 
of the moderate receptors (~0.5 μM). 
 
 
Figure 16: Cooperativity between moderate and weak receptors. Saturation curves for 
LecA binding to GM1 and AGM1 show cooperativity with (a) LacCer and (b) GalβCer. The 
dashed lines represent Hill equation fits to the data (represented as average ± S.D. (n=8)). To 
better show the data points at low concentrations, the binding curves on a semi-log scale are 
shown in APPENDIX C. 
 
 
The cooperativity between the moderate receptors and GalβCer is not as significant as 
LacCer. (Figure 16b) The calculated heterogeneous cooperativity for GalβCer with GM1 is 
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slightly higher than AGM1; however, the cooperativity values for both GM1 and AGM1 systems 
are below two standard deviations. (Table 4) As a result, it is not clear whether there is positive 
cooperativity between GalβCer and moderate receptors. 
 Regardless, we have confirmed that LecA binding capacity enhancement is not 
necessarily limited to just the highest affinity receptor, Gb3, but can also be observed with GM1 
and AGM1 mixtures. This is similar to the case with CTB in which positive cooperativity is 
observed with both GM1 (a strong receptor) and fucosyl-GM1 (a moderate receptor).
18
  
Discussion 
We demonstrated that mixing high-affinity receptors with weaker binding receptors leads 
to increased LecA binding capacity on model membranes. This phenomenon can be accurately 
described using the RD model.
17,18
 Furthermore, in order to initiate cooperative binding, we 
found two conditions must be satisfied. First, there is a minimum LecA concentration required 
before observing significant cooperativity. The minimum concentration corresponds to the 
dissociation constants (Kh) of the highest affinity receptors present in the model membrane.  This 
is evidenced by cooperativity increasing above 0.1 μM LecA for Gb3+LacCer mixture and above 
0.5 μM LecA for GM1+LacCer and AGM1+LacCer mixtures. This criterion is predicted by the 
RD mechanism. In the RD model, the first binding event brings a ligand from solution phase to 
the model membrane; then, the effective receptor concentrations increase for the subsequent 
binding events due to the reduced dimensionality of diffusion. Therefore, it is logical to expect 
the occurrence of hetero-multivalent binding is limited by the first binding event, which 
corresponds to the dissociation constant between LecA and the highest affinity receptor. 
The second criterion is that the weaker receptor has to reach a minimum density. This 
threshold density seems associated with the affinity of the weaker receptor. For Gb3+LacCer 
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mixtures, no obvious cooperativity was observed at 1 mol% of LacCer, but the cooperativity 
drastically increased at 2 mol% of LacCer. When Gb3 was mixed with the moderate receptors 
(GM1 & AGM1), we observed significant cooperativity at 1 mol% of the moderate receptor. 
This observation is similar to the CTB binding system. When comparing two weak CTB 
receptors (dissociation constants of GM2 & GM3: 2mM & 210mM), we observed significant 
cooperativity when a high-affinity receptor was mixed with 1 mol% of GM2, but 1 mol% of 
GM3 was not sufficient to induce hetero-multivalent binding.
18
 However, after raising GM3 to 
14 mol%, the cooperativity was observed.
33
  
The threshold density of LacCer, approximately 2 mol%, is a noticeable portion of the 
total model membrane. This raises the question of whether LacCer in epithelial cells is present in 
sufficient quantities to play a role in LecA binding. To address this concern, we note that 
glycolipids are highly enriched in the apical plasma membrane of polarized epithelial 
cells.
7,161,162
 Additionally, it has been shown that the glycolipid content can reach up to 30% of 
the total membrane lipids in microvilli.
163
 This is significant as the typical total glycolipid 
fraction of the entire membrane for mammalian cells is ~5%.
164
 Furthermore, Parkin et al. 
observed the microvillar membranes in porcine kidney cortex contain 3.53 mass% of LacCer, 
and LacCer was further enriched up to 7.26 mass% in detergent-resistant domains of 
microvilli.
165
 Besides cell polarization, Gb3 can also cluster with galactosyl ceramide, glucosyl 
ceramide, and LacCer in cholesterol enriched domains.
166
 These clustering processes could 
further concentrate local glycolipid abundance. Therefore, it is reasonable to expect that the 
threshold density of LacCer is biologically relevant on a local scale.  
According to the RD hypothesis, the activation of weak receptors increases the total 
amount of available binding sites on membrane surfaces, resulting in increased binding 
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capacities. In the same situation, when a LecA molecule simultaneously binds to Gb3 and 
LacCer receptors, we expected its binding avidity would be lower than that of LecA binding to 
four Gb3 receptors. This hypothesis was supported by our experimental observations. When Gb3 
was mixed with weak and moderate receptors, the Kh value increased. In addition, the colloid 
aggregation measurement exhibited the deceased binding avidity of Gb3+LacCer mixtures. The 
changes of binding capacity and binding avidity may affect downstream processes of LecA. For 
instance, Eierhoff et al. showed that LecA-Gb3 interaction is critical to induce P. aeruginosa 
invagination of giant unilamellar vesicles (GUVs) and H1299 cells.
145
 Based on their theoretical 
model, a higher number of LecA-Gb3 binding events and higher adhesion energy enhance 
membrane engulfment of P. aeruginosa. Therefore, it is reasonable to expect that the potential 
hetero-multivalent binding of LecA influences the invagination process. Another example is that 
Gb3 serves as a signaling receptor for LecA to induce CrkII phosphorylation.
140
 The 
participation of weak receptors, such as LacCer, may change the signaling response. Moreover, it 
has been reported that ligand binding to LacCer can activate Src family kinase Lyn.
167
 Thus, the 
hetero-multivalent binding of lectins introduces a possible secondary role of lectins in the Lyn 
signaling pathway. Further investigation is required to understand the potential role of hetero-
multivalency in various biological systems. 
Besides demonstrating a LecA binding mechanism, we demonstrated the potential of 
using hetero-multivalent binding to improve targeted drug delivery. Traditionally, targeted drug 
delivery schemes have tended to decorate the drug carrier with the highest affinity 
receptors
168,169
; however, this strategy often leads to higher off-target binding. A recent 
computational study suggests that using a combination of multiple weaker affinity ligands can 
improve selectivity, and that selectivity can be further optimized by varying the ligand surface 
 85 
 
densities.
170
 This theoretical study brings to light a new aspect of targeted drug delivery. 
However, using a set of low affinity ligands may reduce the targeting efficiency of drug carriers. 
A potential solution is to decorate weak-affinity ligands on a fluidic liposome surface along with 
a moderate ligand that can facilitate weak ligand-receptor binding via the RD mechanism. Thus, 
we believe liposomal carriers are an attractive approach for the design of multivalent-targeted 
drug delivery systems. 
In our recent work with collaborators, liposome-bacterium studies demonstrate the 
applicability of glycolipid mixtures to achieve improved liposome targeting to P. aeruginosa.
171
 
Specifically, our results yielded two main conclusions. First, adding multiple types of glycolipids 
can significantly improve liposome binding beyond single glycolipid liposomes.
171
 Given the 
observed binding pattern, LecA is probably not the only actor at work in liposome binding to P. 
aeruginosa. We believe other galactose binding adhesins, such as T4P, contribute to the 
observed liposome targeting. Second, the binding between P. aeruginosa and liposomes 
containing only LacCer receptor was negligible.
171
 Therefore, LacCer has to form a partnership 
with the Gb3 receptor in order to exhibit improved liposome retention. This phenomenon is 
consistent with the LecA and CTB binding systems. Weak receptors need the assistance of high-
affinity receptors to initiate hetero-multivalent binding. This phenomenon presents an issue to 
conventional ligand-receptor screening assays (e.g. microarray technology) because they screen 
receptors one by one. As a result, conventional methods may miss the essential weak binding 
receptors, which exhibit high binding selectivity to the target pathogens. Thus, our previously 
published membrane perturbation protocol could provide a more efficient strategy to screen 
potential weak receptors involving P. aeruginosa in binding.
18
 However, there is much work to 
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be done to create a rational basis for a priori targeting design in terms of both affinity and 
selectivity. 
Chapter Conclusion 
Using model membranes, we have shown positive cooperativity of hetero-multivalency 
in LecA and the experimental observations support the RD hypothesis. Furthermore, we found 
that protein concentration and the density of weak receptors in model membranes are critical 
parameters to trigger hetero-multivalent binding. Based on our observations, we expect that the 
localized enrichment of membrane receptors induced by phase separation, dynamics of the cell 
cytoskeleton, cell polarization, and lipid asymmetry can influence the effect of the RD 
mechanism. Further studies are required to dissect the role of the RD mechanism in biological 
systems. 
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CHAPTER V  
SEMI-QUANTITATIVE EVALUATION OF HETEROGENEOUS GLYCOLIPID MIXTURE 
HETERO-MULTIVALENCY USING A TURBIDITY-BASED EMULSION 
AGGLUTINATION (TEA) ASSAY 
 
Chapter Summary 
Lectin hetero-multivalency, binding to two or more different types of receptors, has been 
demonstrated to play a role in both LecA (a Pseudomonas aeruginosa adhesin) and Cholera 
Toxin subunit B (a Vibrio cholerae toxin) binding to glycolipids. This work has been done using 
nanocube sensors. While the nanocube sensors are one of the most high-throughput methods that 
also provide quantitative data, it is preferable to sacrifice some data quality in favor of efficiency 
when screening large molecular libraries. In order to complement the nanocube sensor, we 
present a semi-quantitative turbidity-based emulsion agglutination (TEA) assay for efficiently 
screening lectin binding capacities to heterogeneous lipid surfaces. The benefit of this assay is 
that it relies on the use of emulsions that can be formed in a continuous manner to enable semi-
quantitative high-throughput screening without the bottleneck of functionalization. The TEA 
assay utilizes the lectin-induced aggregation rate of glycolipid stabilized oil droplets to determine 
hetero-multivalency. We demonstrate the correlation of the initial dτ/dt from UV\Vis turbidity 
data and increasing particle size as determined by Dynamic Light Scattering (DLS) to the 
aggregation rate. The aggregation rate in both systems followed the trend observed in our prior 
hetero-multivalent binding capacity results using a nanocube sensor. Therefore, the developed 
TEA assay can be used as a high-throughput tool to screen for hetero-multivalency before 
turning to the batch functionalized quantitative nanocube sensor. 
 88 
 
Introduction 
The exterior surface of cell membranes is densely populated with sugars in what is 
known as the “glycocalyx”.13 This glycocalyx forms the foundation for interactions as diverse as 
cell-cell recognition, host-pathogen recognition, and cell signaling.
13,172-174
  The proteins that 
mediate this interaction by binding to glycans are called lectins.
13
 As the affinity between a 
glycan and a single binding site in a lectin is typically low, lectins utilize multiple subunits to 
bind several glycans simultaneously.
13,172-174
 These multivalent interactions give rise to not only 
stronger overall binding, but also enable modulation of affinity and selectivity of the binding 
lectin.
175-178
  
We recently demonstrated that hetero-multivalency (i.e. a lectin simultaneously 
interacting with different types of receptors) could enhance the binding capacity of lectins to 
model membranes via an inherent Reduction of Dimensionality (RD) mechanism.
17,18,171
  The 
evidence of hetero-multivalency presents a critical issue to conventional ligand-receptor 
screening assays because they do not account for the nature of multivalency and the fluidity of 
cell membranes. To address the issue, we recently introduced a novel nanocube sensor that 
enables label-free detection of protein binding to cell membrane mimicking surfaces using a 
standard laboratory spectrophotometer.
17,18,171
 Although, the nanocube system encompasses 
many unique advantages (e.g. high-throughput utility, absolute quantification without daily 
calibration, easy-to-use, high sensitivity, etc.), a few drawbacks remain.
17,18,171
 The primary 
drawback is that the formation of supported lipid bilayers has to be conducted in a batch process, 
which slows down the overall screening process. This limits the scientific community’s ability to 
screen receptor candidates for hetero-multivalency from a large molecular library.
18
 Therefore, a 
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high-throughput screening system for determining potential receptors involved in hetero-
multivalent binding is desirable. 
A promising system for the high-throughput screening of lectin interactions with 
glycolipids is the agglutination assay.
179
 Lectin-glycan interactions are detected by monitoring 
the lectin-induced aggregation of glycan-coated particles. Classically, this assay was a 
hemagglutination assay in which the lectins that induced red blood cell aggregation indicated the 
donors’ blood group type.180-183 Several groups have used oil in water (O/W) emulsion to replace 
the red blood cells in the hemagglutination assay.
184-188
 Oil droplets are superior to other types of 
agglutination assays in several aspects. First, in contrast to red blood cells, the types and 
densities of receptors on oil droplet are controllable. Second, glycolipids presented at the oil-
water interface maintain the same two dimensional fluidity as on native cell membranes.
189
 
Third, compared to liposome agglutination assays, the higher refractive index of oil droplets 
improves the sensitivity of agglutination measurements at smaller particle sizes.
190
 Fourth, the 
preparation of these emulsions can be done via high-throughput ultrasonication or high-pressure 
homogenization.
191
 Both well-established emulsion methods can generate stable nano-sized 
droplets, typically about 100 nm in diameter.
191-194
 Thus, nano-sized emulsion aggregation 
represents a high-throughput customizable system for hetero-multivalent screening. 
In this paper, we present a turbidity-based emulsion agglutination (TEA) assay to rapidly 
determine potential glycolipid candidates involved in lectin hetero-multivalency.  We have 
demonstrated that LecA from Pseudomonas aeruginosa could induce aggregation of glycolipid 
decorated particles at certain glycolipid compositions;
171
 thus, we used LecA to validate the TEA 
assay. The emulsion aggregation results in changes in solution turbidity. These changes in 
turbidity were measured by a UV/Vis spectrophotometer as graphically represented in Figure 
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17.
184-188,195,196
  Prior studies have determined the relationship between the turbidity of the 
solution at various wavelengths and the particle size, allowing us to quantify the degree of 
agglutination using turbidity.
197,198
 The hetero-multivalency candidates identified by the 
emulsion agglutination assay correlated well with the nanocube experiments performed in our 
recent publication.
171
 In addition, we validated our particle aggregation results using kinetic 
measurements of particle size by DLS and found excellent agreement between these two 
techniques.  
 
 
Figure 17: Schematic of particle aggregation relative to observed changes in absorbance 
at 500 nm. 
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Emulsion Turbidity Theory 
In this article we rely on the analysis of Timasheff.
198
 Using a UV/Vis 
spectrophotometer, we measure the absorbance of the solution as shown in Figure 17. The 
turbidity can be expressed  as a function of emulsion concentration and particle size: 
197
 
Equation 9 
𝜏 =
ln (
𝐼0
𝐼 )
𝑙
= 𝐾𝜋𝑎2𝑁 
where τ = the turbidity; I0 = intensity of the incident light; I = intensity of the transmitted light; l 
= scattering path length; a = the particle radius; N = the concentration of particles; and K = the 
total scattering coefficient which typically varies between 0 and 5.
190
 K is defined as  
Equation 10 
𝐾 = 𝐾0 (
𝑎
𝜆
)
𝑦
 
where Ko = the size-independent component of the scattering coefficient and y is the exponent of 
the wavelength, λ, dependent on the particle size and refractive index. In our analysis, the 
measured absorbance represents the turbidity; thus a 1/2.303 factor is included in Ko. While, the 
y exponent typically varies between -2.2 and 4.0 (Rayleigh scattering) and is given by Timasheff 
as:
198
 
Equation 11 
(
𝜕 ln 𝜏
𝜕 ln 𝜆
)
𝑎
= −𝑦 
For a polydisperse system, turbidity is defined as: 
Equation 12 
𝜏 = 𝐾0∑𝑉𝑖
2
3𝑁𝑖 (
𝑉𝑥
1
3
𝜆
)
𝑦
𝑖
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where Vi = 4/3πai
3
, Ni is the number of particles of radius ai, and:  
Equation 13 
𝑉𝑖 = 𝑥𝑉0 
where x is the degree of polymerization. When the total mass of the associating species is 
constant then: 
Equation 14 
𝑁𝑖 = 𝑁0(1 − 𝑝)
2𝑝𝑥−1 
where N0 is the initial number of particles and p is the fraction of all functional groups reacted 
after a given time, t. Combining this with Equation 12 gives 
Equation 15 
𝜏 =
𝐾𝑁0𝑉0
𝑦+2
3
𝜆𝑦
∑𝑝𝑥−1(1 − 𝑝)2𝑥
𝑦+2
3
𝑖
 
and 
Equation 16 
𝑑𝜏
𝑑𝑡
=
𝐾𝑁0𝑉0
𝑦+2
3 (1 − 𝑝)2
𝜆𝑦
𝑑
𝑑𝑡
∑𝑝𝑥−1𝑥
𝑦+2
3
𝑖
 
where 𝑝 =
1
2
𝑘𝑡
1+
1
2
𝑘𝑡
and k is the rate constant of the second-order condensation 
polymerization/coagulation rate.  For the case of Rayleigh scattering, these equations become, as 
given by Oster: 
Equation 17 
𝜏 =
1
2.303
24𝜋3
𝜆4
𝑛0
4 (
𝑚2 − 1
𝑚2 + 2
)
2
𝑉0
2𝑁0,𝑐(1 + 𝑘𝑡) 
and 
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Equation 18 
𝑑𝜏
𝑑𝑡
=
1
2.303
24𝜋3
𝜆4
𝑛0
4 (
𝑚2 − 1
𝑚2 + 2
)
2
𝑉0
2𝑁0,𝑐𝑘 
where N0,c is the initial number of particles per unit volume, n0 is the refractive index of the 
solvent, and m is the ratio of solute to solvent refractive indices.
196
 From these equations, it is 
clear that dτ/dt is a function of the aggregation rate, k (called the coagulation rate above and by 
Timasheff).
198
 
To ensure that sufficient time was given to allow for particle aggregation, we calculated 
the mean first pass time using the Stokes-Einstein equation: 
Equation 19 
𝐷 =
𝑘𝑏𝑇
6𝜋𝜇𝑎
 . 
where: D is the droplet diffusivity; kb is the Boltzmann constant; T is temperature; and μ is the 
viscosity. Following the analysis of Smoluchowski, the diffusion limited mean first pass time is 
then:
113
  
Equation 20 
𝑡𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛 =
1
4𝜋𝑎𝑁𝐷
 
Therefore, we can calculate τdiffusion be sure that the aggregation rate that we observe from the 
DLS and the turbidity measurements are not diffusion limited aggregation rates.  
  
Methods and Materials 
Materials 
Silicone oil (refractive index of 1.403), PA-IL from Pseudomonas aeruginosa (also 
known as LecA),  and tris-buffered saline (TBS) obtained as a 10x solution (1x working solution 
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20 mM Tris 0.9% NaCl pH ~7.4) were purchased from Sigma-Aldrich (St. Louis, Missouri). 
Calcium chloride was from BDH VWR Analytical (Radnor, Pennsylvania). 
Globotriaosylceramide, Gb3, (Galα1-4Galß1-4Glc-Ceramide), and Lactosylceramide, LacCer, 
(Galβ1-4Glc-Ceramide) were purchased from Matreya LLC (State College, PA). 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) was purchased from Avanti Polar Lipids 
(Alabaster, AL). 
Methods 
Preparation of O/W emulsion 
The desired compositions of lipids in chloroform solutions were mixed in a 25 mL round 
bottom flask and, then, dried using a rotary evaporator (Heidolph Hei-VAP Value
®
). The dried 
lipids were reconstituted using 1X TBS with 100 μM CaCl2, forming multillamellar vesicles 
(MVs) in an aqueous solution. The emulsions were prepared by mixing 5 μL of silicone oil, 
474.18 μL of 1X TBS with 100 μM CaCl2, and 220 μL of MV solution. The mixture was then 
sonicated with a Qsonica Q125 tip sonicator used at 60% amplitude for 1 hour cycling 10 
seconds on and 10 seconds off in an ice bath. The size distributions of oil droplets were 
determined by DLS. 
Kinetic turbidity measurement 
The emulsion was diluted as 20 μL of emulsion into 80 μL of 1X TBS with 100 μM 
CaCl2 in each of six wells of a 96 well plate (Costar
®
 3370) to maintain turbidity in a range of 
0.5 to 0.8 A.U. This was done in order to ensure that the UV/Vis was in the linear response 
region. The turbidity of the emulsions was detected by an ultra-fast UV/Vis microplate 
spectrophotometer equipped with a CCD camera (FLUOstar Omega
®
, BMG-Labtech).   Because 
biological analytes do not significantly absorb light at a wavelength of 500 nm, the turbidity was 
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determined at this wavelength. 10 μL of 3.227 g/L LecA was added to three wells of the 
emulsion to induce agglutination. 10 μL of the buffer was added to the remaining three wells as 
the negative controls. All of the solutions were mixed by pipetting in the well plate. After 
mixing, the turbidity of the emulsions was detected using the microplate spectrophotometer. The 
extinction spectra were collected in the range of 300-1000 nm wavelengths every ~40-60 s for 60 
minutes and then every 30 minutes for 2 more hours at room temperature. Each spectrum was the 
result of averaging 200 flashes per well at a 1 nm resolution. The time from LecA addition to the 
start of turbidity detection was 50 s. The absorbance at 500 nm over the course of 2 min was fit 
with a line to obtain the change in turbidity vs time, dτ/dt. 
Kinetic DLS measurements 
Batch mode hydrodynamic size (diameter) measurements were performed on a Malvern 
Zetasizer Nano ZS90
®
 (Malvern Instruments, Southborough, Massachusetts) at 90°. The 
emulsion was diluted as 10 μL of emulsion into 90 μL of 1X TBS with 100 μM CaCl2 followed 
by equilibration (typically 2 minutes) in the DLS at 25°C before a minimum of three 
measurements per sample were made.  After dilution, the system was checked for multi-particle 
scattering by testing 10 μL of emulsion diluted into 190 μL of 1x TBS with 100 μM CaCl2 to 
ensure that it gave the same particle diameter. Then 5 μL of 3.227 g/L LecA was added to the 
cuvette of the 10 μL emulsion into 90 μL of 1X TBS with 100 μM CaCl2 dilution and mixed by 
pipetting the solution 10 times. A measurement of hydrodynamic size (determined by cumulants 
average or Z- average) via three measurements was then taken every 10 minutes for 2 hours. 
Only results with a polydispersity index (PDI) less than 0.3 were used for fitting to minimize 
errors in calculating particle diameter by method of cumulants. 
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Statistical analysis 
The turbidity testing for each lipid composition was repeated on 3 different days with 3 
technical replicates on each day for a total of 9 replicates. The turbidity data sets were tested for 
normality using the Kolmogorov-Smirnov test in OriginPro 9.1®. In all cases, we could not 
reject the null hypothesis that the data came from normal distributions. Therefore, it was 
reasonable to apply the equal variances and Welch’s unequal variances t-test to the data. For data 
across lipid compositions, the unequal variance t-test was used. For interday data, the population 
data was compared to each individual day’s data of the same lipid composition using the equal 
variance t-test and the coefficient of variance for each lipid composition was calculated. The 
DLS data set is represented as mean ± SE (n=3 runs over each 10 min interval) per lipid 
composition.  
Results and Discussion 
Figure 18 provides example curves of turbidity as a function of time for each bilayer 
composition tested. Initially, the turbidity increases proportionally to particle size as the particles 
exhibit Rayleigh scattering, y ≈ 4 in Equation 11.198 As the particles continue to aggregate, y 
goes from ≈ 4 to -2 indicating a shift from a < λ (y ≈ 4 to 2, Rayleigh scattering region) to a ≈ λ 
(y = 2 to -1, Mie scattering region) and finally to a > λ (y = -1 to -2.2, Airy theory region).190,198  
It should be noted that the plateau region of the turbidity data should not be assumed to be the 
steady state value. Timasheff explains that the plateau region is special case that occurs when y = 
1 and causes scattering to be independent of particle radius yielding a maximum value.
198
 If we 
continue the experiment to longer times, we see an inversion in the dependence of the turbidity 
with particle size and observe a decrease in turbidity when y < 0.
198
 Therefore, the changes in the 
turbidity data are adequately predicted by Timasheff’s theory.  
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Figure 18: Example baseline subtracted turbidity data for each bilayer composition. 
Data is given as a dot plus error bars where the dot is the mean and the error bars are a 
standard deviation, n = 3, D.F. = 2). 
 
 
Given the complexity of calculating the population distribution required for using 
Equation 15, the analysis is greatly simplified by using only the initial linear region of the 
turbidity data. This initial region should follow the predictions of Rayleigh scattering. We 
validated the use of Rayleigh scattering for the initial time points (particle diameter ≤ 275 nm 
and y = 2 to 2.5 for t < 2 min) using the parameters given by Kerker et al. with the cutoff criteria 
as defined by Rahn-Chique et al.
188,199,200
 Kerker et al. defined two parameters, α (the 
dimensionless size parameter) and CRGD (a measure of phase shift), to evaluate the Rayleigh 
scattering, where both are given as
188,199,200
: 
Equation 21 
𝛼 = 2𝜋𝑎/𝜆 
and  
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Equation 22 
𝐶𝑅𝐺𝐷 = (
4𝜋𝑎
𝜆
) (𝑚 − 1). 
when α < 2.0, there is a less than 10% error in using Rayleigh scattering. For our system, α ≤ 1.7 
and CRGD ≤ 0.19 when using 1.338 as the refractive index of 1x TBS buffer.
201
 Our CRGD value is 
less than the Rayleigh scattering threshold (CRGD = 0.22) given by Rahn-Chique et al.
188
 
Therefore, we could use Equation 17 and Equation 18 to interpret the turbidity data. Thus, dτ/dt 
value calculated from the initial slope (t < 2 min) of the turbidity data should be proportional to 
the particle aggregation rate, excluding the influence of multiple scattering.  
There are two primary advantages to performing the analysis in the Rayleigh scattering 
region. First, particle aggregates can induce greater changes in turbidity in the Rayleigh 
scattering region than in the Mie scattering or Airy theory regions, leading to higher sensitivity 
of the turbidity measurement. Second, the initial slope, dτ/dt, of the turbidity data is sufficient for 
relative aggregation rate comparisons. This is because only k will vary in Equation 18 if m, N0, 
V0, and λ are constant. Thus, to ensure that the Rayleigh scattering equations were applicable, the 
analysis was conducted using data for 0-2 minutes, i.e. when the particle diameter is less than 
275 nm, giving α < 2.0 and CRGD < 0.22 for all lipid compositions.  
Although we can use α and CRGD to evaluate the applicability of Rayleigh scattering, the 
particle size is required to determine the parameters. Therefore, a particle size measurement, 
provided by techniques such as DLS, is needed. Another approach to determine whether the 
system is in the Rayleigh scattering region is measuring the y value using turbidity data.  For 
Rayleigh scattering, y should be greater than or equal 2.  This becomes a useful criterion to 
substitute for DLS measurements as y has been linked to the particle size.
202-204
 However, y is 
only a valid approximation of particle size in regions where there is no significant light 
 99 
 
absorption from the molecules, such as the surfactant (lipids, in this case), aqueous phase, and oil 
phase.
202-208
  To ensure the selected wavelengths incident light obeys Rayleigh scattering, we 
used turbidity data over the range of 500-800 nm wavelength to calculate y as given by Equation 
11.
198
 This alternative approach can be useful for scientific communities because only UV\Vis 
measurements are needed to calculate the wavelength exponent, y, in order to determine if we are 
in the Rayleigh scattering region.  However, there are a few potential pitfalls to using this 
method. One pitfall is that the y ≥ 2 criterion assumes the oil and aqueous phases are the silicone 
oil and 1x TBS buffer solutions used in this work. If this is not the case, the Rayleigh scattering 
region is only certain if y = 4. Another pitfall is that the TEA assay should be conducted under 
different droplet concentrations until the turbidity measurements give a consistent initial slope in 
order to avoid multiple scattering.
188
 Thus, the work presented here will simplify future analysis 
with the same system by eliminating the need for subsequent DLS measurements. 
Kinetic DLS Results 
To validate the TEA assay, we first conducted a binding experiment with DLS. The 
results are shown in Figure 19. In each case, a two-fold dilution of the emulsion gave the same 
diameter as before dilution ensuring that our observations were not altered by multiple scattering. 
1 mol% Gb3 + 4 mol% LacCer aggregated the fastest at 5.8 ± 0.3 nm/min (n=6, DF=4). 1 mol% 
Gb3 aggregated about five times slower at 1.16 ± 0.05 nm/min (n=14, DF =12). 4 mol% LacCer 
aggregated at 0.084 ± 0.0045 nm/min (n=8, DF =6), approximately half the rate of 1 mol% Gb3. 
This was greater than the base line aggregation of 100 mol% POPC that corresponds to 
essentially constant particle size. Given the addition of LecA does not induce a change in the 100 
mol% POPC emulsion particle size, we can conclude that any observed increase in particle size 
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is due to the specific interaction of LecA with a glycolipid receptor resulting in droplet 
aggregation. 
 
  
Figure 19: DLS data of average diameter as a function of time since LecA addition. Dots 
with bars represent the average diameter determined from cumulants Z-ave mean ± S.E. (n = 
3) of three tests for each 10 minute time interval with a PDI < 0.3. The dashed line represents 
the fitted slope for each bilayer composition. Inset is a zoomed in view of 4 mol%LacCer and 
100 mol% POPC bilayers. 
 
 
In our prior work with LecA, we observed that lipid surfaces containing both Gb3 and 
LacCer bound more LecA than either Gb3 or LacCer individually.
171
 This indicated that hetero-
multivalency, a protein simultaneously binding to two or more different types of receptors, may 
play an essential role in LecA-glycolipid recognition.
171
 Interestingly, the aggregation rate in the 
DLS seems to exhibit the same behavior as the binding capacity we observed using our nanocube 
system indicating that the DLS aggregation rate can be used to observe hetero-multivalency.
171
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Kinetic Turbidity Results 
After noting that the emulsions’ DLS aggregation rate was correlated to our prior binding 
capacity results, we focused on relating dτ/dt for the Gb3 and LacCer system to the DLS results 
and prior binding capacity data.
171
 The results of this testing across three different days are 
shown in Figure 20. What was immediately obvious is that each day’s three data points were 
part of the same cluster as each other day’s proving the reproducibility of this method. This was 
confirmed in that the data from each day was not significantly (p < 0.05) different from the total 
population and that the coefficients of variation of 9%, 14%, 52%, and 58% for 1 mol% Gb3 + 4 
mol % LacCer, 1 mol% Gb3, 4 mol% LacCer, and 100 mol% POPC, respectively.  The slope of 
1 mol% Gb3 (dτ/dt = 6.6*10-4±0.3*10-4 (n = 9, DF = 8)) was significantly greater (p < 0.001) 
than both 4 mol% LacCer (dτ/dt = 2.2*10-4±0.4*10-4(n = 9, DF = 8)) and 100 mol% POPC(dτ/dt 
= 1.7*10
-4
±0.3*10
-4
(n = 9, DF = 8)). Furthermore, the slope of 1 mol% Gb3 + 4 mol % LacCer 
(dτ/dt = 1.33*10-3±0.04*10-3 (n = 9, DF = 8)) was significantly greater (p < 0.001) than 1 mol% 
Gb3. Therefore, we again saw the same behavior as the nanocube binding capacity in that 1 
mol% Gb3 + 4 mol% LacCer aggregates faster than 1 mol% Gb3 indicating that the TEA assay 
can be used to observe hetero-multivalency.  
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Figure 20: Bilayer reproducibility for four different bilayer compositions. Dots represent 
individual data points across 3 days. Solid black lines represent the mean slope of each 
bilayer. Colored lines represent two SE (n=9) of each bilayer. 
 
 
From Equation 18, we can see that dτ/dt is changing due to a change in the aggregation 
rate, k. Combining this with the DLS result, we can say that dτ/dt is the result of LecA induced 
droplet aggregation that has been correlated to the hetero-multivalency observed in our nanocube 
system.
171
 Furthermore, the ranking given in Figure 20 agrees with the DLS measurement 
ranking for 1 mol% Gb3 + 4 mol% LacCer, 1 mol% Gb3, and 100 mol% POPC. Taken together, 
the data demonstrate that the linear region emulsion turbidity slope, dτ/dt, over longer times is 
strongly correlated to our expectations of hetero-multivalency from the nanocube system.
171
  
TEA Assay Limitations 
Both nanocube sensor data and the DLS results are in close agreement with dτ/dt data. 
This demonstrates the feasibility of using the TEA assay to study hetero-multivalency. However, 
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a few limitations remain with the TEA assay. First, the sensitivity is lower than the DLS and 
nanocube assays. Although the affinity between LacCer and LecA is weak, we could detect 
LecA binding to 4 mol% LacCer lipid surfaces using the DLS and nanocube sensor but not using 
the TEA assay. To improve the sensitivity, we could increase the droplet size. Increasing droplet 
size would result in greater changes in dτ/dt, as turbidity is proportional to a3, resulting in 
improved sensitivity.  However, increasing the droplet size will make the TEA assay approach 
the Mie scattering region, leading to lower sensitivity. In order to minimize this tradeoff, oil 
droplets with higher refractive indices could be used. This is why oil droplet agglutination is 
preferred over liposome agglutination.
209
  
A second limitation is that the TEA assay is semi-quantitative. This is inherent to the 
system as the values of dτ/dt are dependent on the working conditions and are therefore sensitive 
to droplet concentrations and droplet size. The number of droplets is important as it alters the 
mean first pass time. By altering the mean first pass time, you change the fastest aggregation rate 
that can be determined using the system, i.e. the diffusion limited reaction rate. Changing the 
diffusion limited reaction rate modulates the system’s sensitivity range as only aggregation rates 
below the diffusion limit can be differentiated from each other.
196
 The number of droplets is also 
proportional to droplet size, which is important for the reasons stated above.  For the current 
system, the data is also statistically limited to being semi-quantitative. Only 1 mol% Gb3 + 4 
mol% LacCer has a S/N ratio of greater than 10, a typical a priori limit of quantitation 
threshold.
210
 While both 1 mol% Gb3 and 1 mol% Gb3 + 4 mol% LacCer have S/N ratios greater 
than 3, a typical a priori limit of detection threshold.
210
 Thus, using dτ/dt is limited to semi-
quantitative analysis. 
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A third limitation is that the current method only works for Rayleigh scattering below the 
diffusion limited aggregation rate. The limitation of Rayleigh scattering is a choice made in the 
design of the TEA assay so that it is unnecessary to determine the population distribution and so 
that hetero-multivalency can be determined without needing additional measurements of particle 
size.
198
 This enables measurements using only the UV/Vis. On the other hand, the ceiling 
imposed by the diffusion limited rate is inherent to any aggregating system as the particles 
cannot aggregate faster than the time it takes for the particles to diffuse.
113
 This can be worked 
around by increasing droplet concentration thereby lowering the mean first pass time, but the 
observable aggregation rate is eventually limited by the UV/Vis instrument’s detection rate. 
Therefore, the current assay has limitations, but by altering experimental conditions or 
introducing additional measurements those limitations can be mitigated or removed. 
TEA Assay Benefits 
Despite some drawbacks, the TEA assay solves current problems with the tools used to 
study multivalent proteins. First, the TEA assay solves the problem of high-throughput screening 
of hetero-multivalency. For example, if we intend to screen 40 unknown receptors potentially 
involved in hetero-multivalent binding, approximate 800 conditions have to be examined in a 
binary combinatory binding assay. The intrinsic complexity of hetero-multivalency presents an 
issue for all existing assays. The TEA assay is compatible with a microwell plate reader enabling 
quick detection of multiple formulations simultaneously. Furthermore, nano-sized emulsions can 
be formed using continuous methods via sonication or high-pressure homogenization removing a 
key limitation of our nanocube sensor.
191
 Second, the TEA assay provides a second way to 
determine relative hetero-multivalent binding that is easy to use, utilizes only inexpensive and 
widely available reagents, and uses only common laboratory equipment. The result of this is that 
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the TEA assay can easily be adopted in a wide range of biological laboratories. Thus, combined 
with its established reproducibility, the TEA assay is a tool that is amenable to screening of large 
molecular libraries without requiring specialized equipment. 
Chapter Summary 
We have applied emulsion aggregation theory to develop the TEA assay for studying 
complex hetero-multivalency of agglutinating lectins. The TEA assay was shown to correlate 
well with the DLS measured particle size changes induced by the addition of LecA. Furthermore, 
the TEA assay followed the expected results from our prior work reiterating the concept of 
hetero-multivalency in LecA binding to lipid mixtures of Gb3 with LacCer. In conclusion, our 
TEA assay enables the semi-quantitative detection of multivalent protein binding to 
heterogeneous lipid surfaces. Its high-throughput utility will significantly accelerate the receptor 
screening process for hetero-multivalency.  
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CHAPTER VI  
CONCLUSIONS AND FUTURE WORK 
 
In this work, we demonstrated the fundamentals of multivalent lectin binding, proposed a 
two-step binding mechanism (Reduction of Dimensionality, RD), and designed a semi-
quantitative turbidity-based TEA assay for efficient screening of lectin hetero-multivalency. The 
initial demonstration of the fundamentals of multivalent lectin binding was given in Chapter II. 
Following up on this work, a two-step binding mechanism was proposed and validated for the 
binding of CTB to glycolipids in Chapter III. Chapter IV began the validation of the RD 
mechanism for LecA binding. Finally, Chapter V demonstrated and validated the use of 
emulsion turbidity as an efficient way to study lectin hetero-multivalency using droplet  
Besides demonstrating CTB binding fundamentals, Chapter II explored two additional 
points. First, we used a theoretical model developed by Klassen et al to show that homogeneous 
cooperativity (Hill’s coefficient, n) is inversely linked to homogeneous binding capacity.17 This 
explained how CTB could have a higher binding capacity to fucosyl-GM1 as opposed to GM1 
even though GM1 has a higher binding affinity.
17
 Second, we provided a possible explanation to 
the question of why CTB does not correlate with GM1 binding in vivo as posed by Yanagisawa 
et al.
22
 This question could be addressed by both the homogeneous and heterogeneous 
cooperativity observed in CTB binding to glycolipids. Together, these additional points 
supplement the conclusions of Chapter II by providing a theoretical explanation of CTB binding 
to homogeneous lipid bilayers. 
In addition to proposing and providing initial validation of RD for CTB, we introduce 
two further points in Chapter III. First, we demonstrated that heterogeneous cooperativity is not 
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limited to fucosyl-GM1 + GM2.
18
 This is important because it confirms the importance of the 
RD mechanism and the study of heterogeneous mixtures. Second, we established a membrane 
perturbation protocol.
18
 This protocol enables the efficient screening of heterogeneous 
cooperativity receptor candidates by minimizing the number of experimental conditions 
compared to prior binary mixture arrays.
18
 Therefore, Chapter III does more than propose and 
validate the RD model. Chapter III confirms the importance of the RD model by showing it 
applies more generally than a single case and developing a novel method of identification of 
additional systems affected by RD. 
Chapter IV extends beyond the confirmation of the RD mechanism in LecA.  We 
demonstrate additional rules governing heterogeneous cooperativity. Namely, there are threshold 
values of LecA concentration and the weak affinity receptor density that must be achieved before 
heterogeneous cooperativity will be observed.
171
 Thus, Chapter IV extends the RD mechanism to 
introduce important lectin and lipid specific criteria for activating heterogeneous cooperativity. 
In providing an TEA assay amenable to high-throughput emulsion formation and 
screening, Chapter V provides a way to efficiently identify glycolipid mixtures that exhibit 
hetero-multivalency. We provide evidence that LecA induces aggregation in glycolipid stabilized 
oil droplets that is correlated to the lipid surface binding capacity.
211
 This was confirmed by 
measuring particle size as a function of time via DLS. Besides providing an additional system to 
assess hetero-multivalency, the turbidity-based assay enables easy modulation of oil phase 
viscosity to assess the impacts of the RD mechanism in lectin binding. In addition, the assay has 
potential to allow assessment of hetero-multivalency in molecules, such long chain glycolipids, 
that are difficult to incorporate into supported lipid bilayers.
212
 Therefore, Chapter V introduces a 
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TEA assay for lectin binding that allows for the facile screening of receptors for hetero-
multivalency without the functionalization limitations of the nanocube. 
Taken together, Chapters II-V provide an initial framework for understanding and 
utilizing multivalent, especially hetero-multivalent, lectin binding. Initially, this was done by 
highlighting the necessity of understanding how heterogeneous environments alter lectin binding 
in previously unexpected ways. Secondly, this work provided evidence for RD as a central 
mechanism in multivalent binding systems. Third, we provide evidence of lectins binding to 
mixtures of multiple types of receptors. In the LecA system, the binding occurred between 
lactosyl ceramide (LacCer) and Gb3, each of which can trigger signaling pathways.
140,167
 
Therefore, it is possible for heterogeneous multivalent binding to link signaling pathways. 
Lastly, we introduced the option of improving selectivity of lectin systems. This is a result of 
lectins’ ability to bind to receptor mixtures enabling tuning of a lectin inhibitor using two or 
more receptor types. This is in contrast to prior lectin inhibitor optimization that typically 
focused solely on tuning lectin binding with a single receptor type.
25,40,213
 Thus, we developed an 
initial framework for understanding multivalent lectin binding with consideration to elucidating 
biologically relevant phenomena and improving lectin inhibition. 
Building upon the work presented here, a future direction of this work is to establish a 
method to theoretically predict heterogeneous cooperativity from monovalent binding affinity 
and capacity. Successful development of a theoretical prediction method would be beneficial to 
the scientific community in several ways. First, such a method would enable the a priori design 
of drug delivery schemes based on mixed receptor bilayers and facilitate the tuning of relevant 
parameters, such as binding affinity, capacity, and selectivity.
171
 Second, a theoretical method 
should greatly simplify the identification of new systems that exhibit hetero-multivalency. This 
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would be accomplished by limiting the number of tests required to only the most likely 
conditions as determined by theoretical prediction of heterogeneous cooperativity. The 
development of a theoretical prediction method also seems feasible. One reason is that the RD 
model does not necessarily require measurements of the mixture meaning that individual binding 
data and physical properties should be sufficient.
18,171
 Another reason is that we have already 
established that heterogeneous cooperativity activation is correlated to receptor binding affinity. 
Thus, the development of a theoretical prediction method would be beneficial to the scientific 
community and seems feasible based on preliminary evidence. 
A second future direction of this work is to expand the membrane perturbation protocol 
to extracted cell membranes. Development of this method should enable quick assessment of 
host-pathogen interactions for cooperativity. This would detect relevant binding receptors that 
are missed by current techniques.
17
 Furthermore, the facile doping of the bilayer with additional 
glycolipids should also work in concert with the aforementioned theoretical prediction method to 
confirm any predictions of hetero-multivalency. This expansion of the membrane perturbation 
protocol could be quickly applied to the TEA assay as it only requires incorporation of the 
membranes with the oil and buffer. Furthermore, this expansion should also be compatible with 
the nanocube system, albeit with a bit more work than the TEA assay. The primary reason is that 
coating of epithelial and bacterial outer cell membranes has been demonstrated for planar 
supported lipid bilayers.
212,214,215
 Therefore, the coating of nanocubes using analogous methods 
should be achievable. A secondary reason is the ability to co-adsorb doping glycolipids vesicles 
along with the extracted cell membranes providing an easy way to modulate glycolipid densities 
required for the membrane perturbation protocol. As a result, the expansion of the membrane 
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perturbation protocol should be an achievable future direction and greatly influence analysis of 
heterogeneous lectin binding especially in less understood lectins. 
A third future direction of this work is to further validate the RD mechanism. In Chapter 
III and Chapter IV, we demonstrated strong support for the RD mechanism. However, we did not 
establish the relative contributions of allosteric regulation and the RD mechanism to the 
enhanced binding capacity caused by hetero-multivalency. Elucidating the relative contributions 
may be beneficial as it can assist in the development of a theoretical prediction method for 
hetero-multivalency. This elucidation may be possible by cross-linking the lectin subunits to 
keep their native state before binding to any glycolipids.
216
 Once cross-linked, the lectin can be 
bound to a mixed glycolipid receptor membrane and the binding capacity evaluated. If hetero-
multivalency is observed, then we can compare its relative amount to that observed with uncross-
linked lectins to determine the contribution of allosteric regulation. This effect can be confirmed 
by crosslinking the lectin subunits after binding to glycolipids to establish any conformational 
changes.
217
 Thus, the difference between the native state cross-linked lectin and the unmodified 
lectin binding would give the relative contribution of allosteric regulation to hetero-multivalency 
and provide additional insights into how to theoretically predict when hetero-multivalency will 
occur and the extent of binding capacity enhancement. 
In conclusion, this work has achieved its stated goal. Namely, in this work, we 
demonstrated the fundamentals of multivalent lectin binding, proposed a two-step binding 
mechanism (RD), showed that the RD mechanism applies in a second multivalent lectin system, 
and developed a TEA assay amenable to high-throughput emulsion formation and screening. 
This work can be readily expanded in three primary ways. First, a method to theoretically predict 
-multivalency could be developed. Second, the membrane perturbation protocol can be extended 
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to extracted cell membranes. Third, the relative contributions of allosteric regulation and the RD 
mechanism to hetero-multivalency could be quantified. Thus, the work presented here provides 
the foundation for a rational basis of understanding and utilizing hetero-multivalency and its 
effects on lectins binding to glycolipids.  
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APPENDIX A* 
     Theoretical Model 
A model for the binding of GM1 to CTB was proposed by Klassen and his coworkers.
64
(Figure 24). We adapted and analyzed their stepwise binding model with minor changes. All 
equations are summarized below. Writing the material balance for a pentameric protein P, 
Equation 23 
PT = [P] + [PL] + [PL2
′ ] + [PL2
′′] + [PL3
′ ] + [PL3
′′] + [PL4] + [PL5]
where PT is the total concentration of protein, [P] is the concentration of free protein, and 
[PL]/[PL2]/[PL3]/[PL4]/[PL5] are the protein-ligand binding complexes with 1, 2, 3, 4, and 5 
ligands/receptors respectively. [PL2] and [PL3] contain two bound states ([PL2’]/ [PL2’’] and 
[PL3’]/ [PL3’’]) that were defined by Klassen’s model. 
64
Writing material balance for the ganglioside L, 
Equation 24 
LT = [L] + [PL] + 2([PL2
′ ] + [PL2
′′]) + 3([PL3
′ ] + [PL3
′′]) + 4[PL4] + 5[PL5]
where LT is the total concentration of ganglioside and L is concentration of unbound 
gangliosides. At equilibrium, the material balances for each reaction species were written as 
follows: 
Equation 25 
[PL] = 5K1[P][L]
Equation 26 
[PL2
′ ] = K2[PL][L] = 5K1K2[P][L]
2
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Equation 27 
[PL3
′ ] = K2[PL2
′ ][L] = 5K1K2
2[P][L]3 
Equation 28 
[PL4] = K2[PL3
′ ][L] = 5K1K2
3[P][L]4 
Equation 29 
[PL5] =
K3
5
 [PL4][L] = K1K2
3K3[P][L]
5 
Equation 30 
[PL2
′′] = K1[PL][L] = 5K1
2[P][L]2 
Equation 31 
[PL3
′′] = K2[PL2
′′][L] = 5K1
2K2[P][L]
3 
Equation 23 and Equation 24 then become: 
Equation 32 
PT = [P] + 5K1[P][L] + 5K1K2[P][L]
2 + 5K1
2[P][L]2 + 5K1K2
2[P][L]3 + 5K1
2K2[P][L]
3
+ 5K1K2
3[P][L]4 + K1K2
3K3[P][L]
5 
Equation 33 
LT = L + 5K1[P][L] + 2(5K1K2[P][L]
2 + 5K2
2[P][L]2) + 3(5K1K2
2[P][L]3 + 5K1
2K2[P][L]
3)
+ 4(5K1K2
3[P][L]4) + 5K1K2
3K3[P][L]
5 
Klassen and his coworkers 
64
 determined the values for K1, K2, and K3 for CTB binding 
with GM1 to be 3.2x10
6
 M
-1
, 5.5 x10
6
 M
-1
, and 9.5 x10
6
 M
-1
, respectively. To account for 
cooperativity, we multiplied K2 and K3 with a factor ‘α’  
Equation 34 
𝐾2 = 𝛼 × 𝐾1 , 𝐾3 = 𝛼
2  ×  𝐾1 
α is approximately 2 when GM1 is the binding receptor and α <1 represents negatively 
cooperative binding. From the fitting results of the Hill-Waud equation, we found the binding 
cooperativity of CTB to fucosyl-GM 1 was significantly reduced from CTB to GM1 binding; 
hence, we considered the value of α to be less than 2. Although we selected an arbitrary α = 1/2 
 133 
 
to demonstrate the enhanced binding capacity in Figure 4a, the increase of binding capacity was 
observed for all tested values of α smaller than the 2, representative of GM1 binding to CTB.  For 
all theoretical modeling, we set the total ganglioside concentration initially to 10
-6
 M (a similar 
order of magnitude as the experiments performed), and changed the concentration of unbound 
CTB from 10
-10
 to 10
-6 
M , and then we solved Equation 33 to obtain [L]. Therefore, we could 
determine the concentration of the bound CTB by adding Equation 25 to Equation 31.  
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Figure 21: TEM image comparison of silica coating procedures. (a) A TEM image of the 
silica shell coated onto Ag nanocubes in 2-propanol. (b) A TEM image of the silica shell 
coated onto Ag nanocubes in ethanol. Reprinted with permission from Worstell et al.
75
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Figure 22: Equilibrium StP- Biotin binding for sensor calibration. Streptavidin (StP)-
biotin-DPPE binding data assuming that all StP is bound to a biotin group resulting in the 
observed LSPR shift. Data are reported as mean ± S.D. (n=8). Reprinted with permission 
from Worstell et al.
75
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Figure 23: GM1 quality comparison across vendors. Comparison of GM1 gangliosides 
obtained from various companies with fucosyl-GM1 plotted for reference. Data are reported 
as mean ± S.D. (n=8). Reprinted with permission from Worstell et al.
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Figure 24: Stepwise CTB binding model with a single type of ganglioside. The stepwise 
model is adapted from.
64
 Reprinted with permission from Worstell et al.
75
 
 
 
 
Figure 25: Effect of varying cooperativity and binding affinity (with a reduced K1 to 
half its original value). Reprinted with permission from Worstell et al.
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Figure 26: CTB bound as a function of unbound CTB concentration for each of the 
possible binding states. Reprinted with permission from Worstell et al.
75
 
*Reprinted with permission from “Hetero-multivalent Binding of Cholera Toxin Subunit 
B with Glycolipid Mixtures” by Krishnan, Pratik, Singla, Akshi, Lee, Chin-An, Weatherston, 
Joshua D., Worstell, Nolan C., Wu, Hung-Jen, 2017, Colloids and Surfaces B: Biointerfaces, 
160,281-288, Copyright 2017 by Elsevier B.V. 
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APPENDIX B* 
Calculation of Reduction of Dimensionality 
As described in the main text, the reaction rate, 𝜙, can be written as114: 
Equation 35 
𝜙 = 𝑘𝑜𝑏𝑠𝐶𝐴𝐶𝐵  
where 𝐶𝐴 and 𝐶𝐵 are the number densities of the two reactants, and 𝑘𝑜𝑏𝑠 is the empirical rate 
constant. The reactant concentrations are measured in either units of 𝑚𝑜𝑙/𝑚3 for bulk reactions 
or 𝑚𝑜𝑙/𝑚2 for surface reactions. Thus, the three-dimensional reaction rates (𝜙3𝐷) are in units of 
𝑚𝑜𝑙/(𝑚3 ∙ sec ); on the two-dimensional membrane surface, the unit of reaction rate (𝜙2𝐷) is 
𝑚𝑜𝑙/(𝑚2 ∙ sec ). To evaluate the difference between three-dimensional and two-dimensional 
reactions, the two-dimensional reaction rate was multiplied by a constant 𝑆/𝑉 in order to covert 
the surface concentration to volume concentration. 𝑆 is the total surface area of the outer leaflet 
of liposome confined in volume 𝑉. Using the DOPC lipid footprint in bilayer of 0.72nm2,120 the 
total surface area of outer leaflet of liposome containing 1 mol% of glycolipid can be estimated: 
Equation 36 
𝑆
𝑉
= (
𝐶𝐵,3𝐷
1%
) ∙ 𝑁𝐴 ∙ 0.72𝑛𝑚
2/2 = 6.5 × 103𝑚−1 
Thus, the reaction events per volume per time occurring on two-dimensional membrane surfaces 
is: 𝜙2𝐷 ∙ (𝑆/𝑉) 
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In order to consider the influence of diffusion processes, we estimated the reaction rate in 
diffusion controlled reactions. For three-dimensional reactions, Smoluchowski equation 
gives
109,114
: 
Equation 37 
𝑘𝑜𝑏𝑠,3𝐷 = 4𝜋𝑁𝐴𝑎(𝐷𝐴,3𝐷 + 𝐷𝐵,3𝐷) 
where 𝑁𝐴 is Avogadro's number, 𝑎 is the encounter radius. Here, we assumed the encounter 
radius is equivalent to the head group size of DOPC in bilayer (√0.72𝑛𝑚2/𝜋 = 0.48𝑛𝑚). three-
dimensional diffusivities of CTB and glycolipid containing liposome were estimated using 
Stokes-Einstein equation. (𝐷𝐴,3𝐷 =  9.77 x10
−11  𝑚2 𝑠⁄  and 𝐷𝐵,3𝐷  =  4.88 x10
−12  𝑚2 𝑠⁄ ) 
For two-dimensional reactions, prior studies derived several analytical solutions using 
various approaches. We selected three classic models to evaluate the approximate reaction rate 
on two-dimensional membrane surfaces.
113-115
 Hardt employed the approximate solution of mean 
diffusion time derived by Adam and Delbrück
109
  and calculated the two-dimensional reaction 
rate
113
: 
Equation 38 
𝑘𝑜𝑏𝑠,2𝐷 = 2𝜋𝑁𝐴
(
 
 𝐷𝐴,2𝐷
𝑙𝑛
1
𝑎√𝜋𝑁𝐴𝐶𝐵,2𝐷
+
𝐷𝐵,2𝐷
𝑙𝑛
1
𝑎√𝜋𝑁𝐴𝐶𝐴,2𝐷)
 
 
 
where 𝐷𝐴,2𝐷 and 𝐷𝐵,2𝐷 are the two-dimensional diffusivity of CTB and glycolipid obtained from 
the literature (𝐷𝐴,2𝐷 =  2.5 × 10
−13  𝑚2 𝑠⁄  and 𝐷𝐵,2𝐷  =  8.25 × 10
−12  𝑚2 𝑠⁄ ).118-120 𝐶𝐴,2𝐷 and 
𝐶𝐵,2𝐷 are the surface densities (unit:𝑚𝑜𝑙/𝑚
2). Szabo et al. applied the first passage time 
approach to evaluate the surface reaction rate.
115
 Keizer showed the solution for diffusion 
controlled reactions:
114
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Equation 39 
𝑘𝑜𝑏𝑠,2𝐷 = 2𝜋𝐷′/(𝑙𝑛(𝑏/𝑎) − 3/4) 
where 𝐷′ = 𝐷𝐴,2𝐷 +𝐷𝐵,2𝐷, and 𝑏 represents the diffusion distance. If CTB  serves as the sink for 
the glycolipid, we can obtain 𝑏 = √1/𝜋𝑁𝐴𝐶𝐴,2𝐷.
113
  Keizer reported a similar formula for  
𝑘𝑜𝑏𝑠,2𝐷 using a statistical thermodynamic theory: 
Equation 40 
𝑘𝑜𝑏𝑠,2𝐷 = 2𝜋𝐷′/(𝑙𝑛(𝑏/𝑎) − 𝛾 + 𝑙𝑛√2) 
where 𝛾 is the Euler’s constant = 0.5772…  
In our experiments, the glycolipid concentration (𝐶𝐵,3𝐷) was controlled at 300 nM. 
Considering 300 nM of CTB, the two-dimensional reaction rate is around 10
4
 higher than three-
dimensional reaction rate. (𝜙2𝐷 ∙ (𝑆/𝑉)/𝜙3𝐷 = ~8,000 for Equation 38, ~13,000 for Equation 
39, and ~9,000 for Equation 40). Even if we consider the diffusivity value of GM1 reported in 
literature 
121,122
, the two-dimensional reaction rate is still 5000-10000 times higher than the three-
dimensional reaction rate. At higher CTB concentrations (𝐶𝐴,3𝐷 = 700𝑛𝑀), the two-dimensional 
reaction rate could be up to 20,000 times higher than the three-dimensional reaction rate. In 
general, the reduction of dimensionality mechanism can enhance two-dimensional reaction rate 
by 3-4 orders of magnitude.  
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Figure 27: TEM images of the silica shell coated onto the Ag nanocubes. Scale bar = (a) 
40nm and (b) 20nm. Reprinted with permission from Krishnan et al.
18
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Figure 28: Sensor sensitivity characterization. Change in quadrupole LSPR peak location 
vs. Refractive Index (RI) using silica coated silver nanocubes in various glycerol-water 
mixtures measured with a spectrophotometer. The slope is 187.44 nm/RIU. Reprinted with 
permission from Krishnan et al.
18
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Figure 29: Equilibrium binding of CTB to membrane surfaces containing two 
glycolipids in a 1:1 mole ratio (1 mol% of each glycolipid). The CTB concentration used 
was 706 nM. Reprinted with permission from Krishnan et al.
18
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Figure 30: Equilibrium binding of CTB to membrane surfaces containing two 
glycolipids in a 1:1 mole ratio (1 mol% of each glycolipid). The CTB concentration used 
was 1726 nM. Reprinted with permission from Krishnan et al.
18
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APPENDIX C 
Aggregation Kinetics Theory 
To study the interaction between colloidal particles mediated by biomolecular 
interactions of LecA with glycolipids, we used the method as outlined by Duncan et al. for 
Concanavalin A binding to dextran.
155
 The binding energy between LecA and glycolipid 
receptors was quantified using the single particle disappearance rate. However, we needed to 
identify the relevant time scales in which single particle-single particle interactions should 
dominate. This was done by calculating the mean diffusion time of first interaction for particles 
via the pair potential energy excluding biomolecular interactions in order to capture all relevant 
dynamics. The derivation of the theoretically predicted time scale based on the initial particle 
distribution is as follows. 
Particle-Particle & Particle-Wall Interaction Potentials 
For macromolecule-coated, micron-sized colloids, the interaction potential, u, that can be 
constructed as separate particle-wall and particle-particle interactions in which the upw is given 
by Duncan et al. as
155
: 
Equation 41 
𝑢𝑝𝑤(ℎ) = 𝑢𝐺(ℎ) + 𝑢𝑣(ℎ) + 𝑢𝑠(ℎ) 
where h is the particle-wall hard surface separation, r is the particle center-particle center 
separation and the subscripts are G (for gravity), v (for van der Waals), and S (for steric). The 
potential energy due to gravity is: 
Equation 42 
𝑢𝐺(ℎ) =
4
3
𝜋𝑎3(𝜌𝑝 − 𝜌𝑓)𝑔ℎ 
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where a is the particle radius (2520 nm), g is the acceleration due to gravity, and ρp and ρf are the 
particle and fluid densities, respectively. 
218
 The van der Waals potential between half spaces was 
calculated using Lifshitz theory with consideration of retarded and screened interactions in 
dielectric media as reported in our prior publication.
156
 The values of water, polystyrene, and 
silica dielectric spectra are the same as those reported previously.
219
 The particle-particle and 
particle-wall interactions were corrected by Derjaguin approximations.
220
 For convenience, the 
van der Waals interactions calculated by Lifshitz theory and Derjaguin approximation are fitted 
to inverse power laws as: 
Equation 43 
𝑢𝑝𝑤𝑣𝑑𝑊(ℎ) = −𝐴𝑝𝑤𝑎ℎ
−𝑝 
where App, Apw and p for Equation 43 are effective Hamaker constants. The fitted parameters for 
Equation 43 (silica particle-polystyrene well plate bottom) are Apw = 0.3322 and p = 1.141. The 
steric potential represents the nonspecific osmotic repulsion due to macromolecules and is 
modeled as short range exponentials by Everett et al 
218
 as: 
Equation 44 
𝑢𝑠
𝑝𝑤(ℎ) = 𝐵𝑒[−𝜅(ℎ−𝛿𝐻𝑊)] 
where κ is the inverse decay length and B is the intercept at separation. δHW is defined as the 
thickness of macromolecule layer (lipid bilayer is approximately 5 nm
218,221
 and the thickness of 
F127 on polystyrene is 10 nm). 
159
 Thus, δHW = 16 nm in Equation 44.  
Hydrodynamic Effects on Particle Diffusion 
Particle diffusion in the bulk fluid is given by the Stokes-Einstein equation 
Equation 45 
𝐷𝑜 =
𝑘𝐵𝑇
6𝜋𝜇𝑎
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when a particle stays near a planar surface, the particle-surface hydrodynamic interactions hinder 
the particle’s diffusion parallel to the surface as given by: 
Equation 46 
𝐷𝑝𝑤,‖(ℎ) = 𝐷𝑜𝑓𝑝𝑤,‖(ℎ) 
where the correction factor, 𝑓𝑝𝑤,‖ is the function of particle-surface separation, reported by Wu et 
al. 
222
: 
Equation 47 
𝑓𝑝𝑤,‖(ℎ) =
12420𝛼(ℎ)2 + 5654𝛼(ℎ) + 100
12420𝛼(ℎ)2 + 12233𝛼(ℎ) + 431
 
where 𝛼(ℎ) = ℎ/𝑎. Thus, the average lateral diffusion of particle depends on the interactions 
between a particle and a planar surface as given by
223
 
Equation 48 
〈𝐷𝑝𝑤,‖〉 =
∫𝐷𝑝𝑤,‖(ℎ)𝑝(ℎ)𝑑ℎ
∫ 𝑝(ℎ)𝑑ℎ
 
where  𝑝(ℎ) represent the distribution of particle elevation that is determined by Boltzmann 
equation: 
Equation 49 
𝑝(ℎ) = 𝐴𝑒
−𝑢𝑝𝑤
𝑘𝐵𝑇  
Besides the wall hindering diffusion, particle-particle multibody hydrodynamics also play 
a role in further hindering the lateral diffusion in concentrated colloidal systems. This diffusion 
along the line of particle centers is given as
155
: 
Equation 50 
𝐷𝑝𝑝,⊥(𝑟) = 〈𝐷𝑝𝑤,‖〉𝑓𝑝𝑝,⊥(𝑟) 
where 𝑓𝑝𝑝,⊥(𝑟) is given by Honig et al.
224
 as 
1
𝛽(𝑢)
. β(u) is defined as: 
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Equation 51 
𝛽(𝑢) ≅
6𝑢2 + 13𝑢 + 2
6𝑢2 + 4𝑢
 
where 𝑢 = (𝑟 − 2𝑎)/𝑎.  
 
Finally, τ is the two dimensional diffusion time required for the particles to come into 
contact and defined as 
113
: 
Equation 52 
𝜏 = (2𝜋𝜙1,0𝐷𝑝𝑝,⊥(𝑟))
−1
ln [
(𝜋𝜙1,0)
−
1
2
𝑟𝑐
] 
where rc is the collision radius taken as rc=a + 0.5 * δHW,pp  where δHW,pp=12 nm and r is taken as 
𝑟 = (𝜙1,0)
−
1
2 corresponding to the average separation between particles.  τ is the value that we 
used as a cut off time for measuring single particle aggregation rates. 
 
 
Figure 31: Cartoon representations of glycolipids used in Chapter IV. 
 
 150 
 
 
Figure 32: Saturation curves for LecA binding to pure galactose terminated glycolipids 
given in semi-log form. The data are represented as mean±S.D. (n=8). The dashed lines are 
the Hill equation fits to the data. 
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Figure 33: Saturation curves for LecA binding to Gb3, GM1, or AGM1 with LacCer 
bilayers as given in semi-log form. The data are represented as mean±S.D. (n=8). The 
dashed lines are the Hill equation fits to the data. 
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Figure 34: Saturation curves for LecA binding Gb3, GM1, AGM1, or GalβCer mixed 
together given in semilog form. The data are represented as mean±S.D. (n=8). The dashed 
lines are the Hill equation fits to the data. 
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Figure 35: Predicted ϕ values (represented as a linear interpolated lines between the 
calculated mean values at various [LecA] for a variety of bilayer mixtures). 
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Table 5: Hill’s equation parameters obtained by fitting in OriginLab. A * indicates that 
fitting was highly uncertain due to the data not reaching a plateau and – indicates fitting did not 
converge. The values are represented as a mean±SE (where the standard error of the fit is based 
on fitting 96 points for each curve). 
Lipid Compositions (mol%) Fitted Parameters 
Gb3 GM1 AGM1 LC Gal
ß 
 POPS POPC Vm (μM) Kh (μM) n  
1 0 0 0 0 10 89 1.53±0.02 0.09± 0.00 2.68±0.24  
0 1 0 0 0 10 89 0.10±0.03 0.13± 0.00 0.00±0.40 * 
0 5 0 0 0 10 85 4.37±0.08 0.48± 0.02 1.36±0.05  
0 0 1 0 0 10 89 0.44±0.06 1.10± 0.17 2.64±0.77  
0 0 5 0 0 10 85 3.58±0.04 0.37± 0.01 2.11±0.08  
0 0 0 4 0 10 86 - - - * 
0 0 0 8 0 10 82 6.41*103±3.48*107 
3.48 3.48E+07 
3.76*106±3.15*1010 
3.15*10^10 
0.65±0.22 * 
0 0 0 0 4 10 86 0.12±0.04 0.18±0.00 0.00±0.42 * 
0 0 0 0 8 10 82 - - - * 
1 1 0 0 0 10 88 3.24±0.04 0.19±0.01 1.26±0.04  
1 0 1 0 0 10 88 3.30±0.04 0.20±0.01 1.50±0.07  
1 0 0 1 0 10 88 1.83±0.04 0.12±0.01 1.08±0.07  
1 0 0 2 0 10 87 2.81±0.04 0.11±0.01 1.39±0.11  
1 0 0 4 0 10 85 3.18±0.04 0.17±0.01 1.16±0.05  
1 0 0 8 0 10 81 3.75±0.04 0.13±0.00 1.35±0.05  
1 0 0 0 8 10 81 2.11±0.02 0.09±0.00 1.92±0.14  
0 1 1 0 0 10 88 4.24±0.51 3.02±0.51 1.34±0.07 * 
0 1 0 4 0 10 85 9.30*103±1.96*107 3.81*105±1.05*109 0.8±0.1 * 
0 1 0 8 0 10 81 3.26±0.08 1.17±0.03 2.08±0.08  
0 1 0 0 8 10 81 3.21*102±8.42*104 1.84*104+6.86*106 0.71±0.22 * 
0 0 1 4 0 10 85 14.32±16.95 13.67±18.53 1.15±0.13 * 
0 0 1 8 0 10 81 3.91±0.13 1.66±0.07 2.00±0.08  
0 0 1 0 4 10 85 0.49±0.03 1.61±0.05 14.62±4.13  
0 0 1 0 8 10 81 5.95*103±1.85*107 6.12*105±2.62*109 0.73±0.18 * 
 
 
